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The kinamycin antibiotics produced by Streptomyces 
murayamaensis are derived from an angucycline polyketide 
intermediate, dehydrorabelomycin.  Tetrangulol from 
Streptomyces rimosus and PD  116740 from Streptomyces WP  4669 
are also angucycline polyketides.  In order to clone the polyketide 
biosynthetic genes of S.  murayamaensis, a bacteriophage genomic 
DNA library was constructed and 25 putative PKS gene clones were 
obtained in previous work.  This work started by subcloning the 
inserts from these lambda clones into either the Streptomyces 
plasmid  pIJ941  or the Streptomyces-Escherichia  coli shuttle vector 
pKC1218.  These subclones were then to be transformed into 
Streptomyces  lividans and Streptomyces parvulus for expression 
testing.  However, expression was not successful, presumably due 
to the lack of key genes on the relatively small pieces cloned (15­
20 kb).  Cosmid genomic DNA libraries of S. murayamaensis, as 
Redacted for Privacywell  as  of S.  rimosus and S.  WP  4669  were  then  constructed  in  E. 
coli  XLI-Blue MR  using  the  Streptomyces-E.  coli  bifunctional 
cosmid,  pOJ446.  Approximately  6000  individual  colonies  of the  S. 
murayamaensis  cosmid  library  and  about  2500  individual  colonies 
of the  S.  rimosus  and  S.  WP  4669  cosmid  libraries  were  screened 
with  act/-ORFI,  the  ketosynthase  gene  from  the  actinorhodin 
pathway.  From  these  cosmid  libraries  39,  12,  and  38  positive 
clones  were  identified  respectively,  from  S.  rimosus, S.  WP  4669, 
and  S.  murayamaensis.  Restriction  analysis  and  Southern 
hybridization  showed  that  there  are  two  polyketide  biosynthetic 
gene  clusters  in  each  orgamsm.  Transformation  of  the  cosmids  into 
S.  lividans  TK24  followed  by  HPLC  analysis  of  the  fermentation 
extracts  indicated  that  one  of the  clusters  from  S.  murayamaensis 
represented  the  kinamycin  pathway,  one  of  the  clusters  from  S. 
rimosus  represented  the  tetrangulol  pathway,  and  one  of  the 
clusters  from  S.  WP  4669  represented  PDII6740  pathway.  Thus, 
heterologous  expression  of  a  derivative  compound  of  a  kinamycin 
biosynthetic  intermediate  was  obtained  in  the  first  case,  and 
expression  of  tetrangulol  and  of PD116740  was  obtained  In  the 
second  and  third  cases,  respectively.  Expression  of  these 
compounds  by  the  S.  lividans  transformants  was  detected  by 
photodiode  array-HPLC  analysis  of  crude  extracts  and  was  further 
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Chapter  I 
Introduction 
The polyketides are a group of organic molecules produced 
through the successive condensation of small carboxylic acids such 
as acetate, propionate, or  butyrate.1-3  Even though the 
polyketides are biosynthesized from the same building blocks and 
share a common pattern of biosynthesis, their structures are 
extremely diverse (Figure I-1). 
The polyketides are examples of secondary metabolites, so called 
because the secondary metabolism is not essential for, and plays 
no part in, growth, in contrast to the primary metabolism that 
provides the structure and energy requirements of all living cells. 
The polyketides are found in both prokaryotes and eukaryotes in 
nature, except for the animal kingdom.1-3  Typical examples of 
polyketides are the striking polyketide-derived colors of the 
flowers and the flavors of higher plants, the phytoalexins that help 
to defend crop plants against fungal disease, mycotoxins in fungi, 
and the polyketide-derived antibiotics of Streptomyces sp. 2 
OH  0  COOH 
6-methylsalicylic  acid  Actinorhodin 
CH 20H HO 
i.o0 OH  =  OCH3 0  OH 
PD116740 Erythromycin 
Brevetoxin  B 
Figure  I-1.  Structural  diversity  of  polyketides 3
 
The polyketide-derived compounds of Streptomyces, especially, 
have attracted attention because they have many significant 
biological activities such as antifungal, antibacterial, antitumor, and 
anthelmintic properties.  The wide variety of their biological 
properties reflects the diversity of polyketide structure (Figure I­
1).  6-Methylsalicylic acid, which is derived from an eight-carbon 
chain that cyclized to form an aromatic ring is the smallest 
polyketide known so far.  The largest known polyketide is 
brevitoxin B, with 50 carbon atoms in its chain. 
Mechanism  of  polyketide  biosynthesis 
From the results of radio-isotope feeding experiments, Birch 
suggested that polyketides are synthesized through a mechanism 
similar to the formation of long-chain fatty acid biosynthesis from 
carboxylic acid building units.4  Cloning of the first whole 
polyketide biosynthetic gene cluster, the one for actinirhodin from 
Streptomyces coelicolor by Hopwood et al, opened a new era for 
understanding polyketide biosynthetic mechanisms.5,6  Molecular 
genetic studies of polyketide biosynthetic  pathwaysl -3 have 
confirmed the idea of analogy between formation of long chain 
fatty acids and synthesis of polyketides. 
Fatty acid synthase (FAS) catalyzes repeated decarboxylic 
condensing reactions of malonyl-CoA to synthesize a fatty acid.  In 
prokaryotes and higher plants, it is a multienzyme complex (so 
called Type II FAS).1,2,10  In this case, separate polypeptides 
catalyze each step in fatty acid biosynthesis.  The Type I fatty acid 4
 
synthase is a huge multifunctional polypeptide catalyzing all of the 
steps in fatty acid biosynthesis.'-3  The Type I FAS is usually 
active as a homodimer and is typical of animal systems. 
Figure 1-2 illustrates the general concept of how a fatty acid is 
biosynthesized.  Chain building starts by transferring an acetyl unit 
from acetyl-CoA to the active-site cysteine residue of the  13­
ketoacyl synthase (KS) by acetyl-CoA-acyl carrier protein (ACP) 
transacylase.  Next, the building unit, malonate, is transferred from 
coenzyme A (CoA) to the pantotheine arm on the acyl carrier 
protein (ACP) by the acyltransferase (AT).  Decarboxylative 
condensation occurs between the ACP-bound malonate and the 
acetyl unit of KS.  The resulting acetoacetyl-ACP usually proceeds 
through a complete reductive cycle comprising a 13-keto-reduction, 
a dehydration, and an enoyl-reduction, by the action of the 13­
ketoreductase (KR), dehydrase (DH), and enoylreductase (ER), 
respectively.  The growing chain is then transferred to the KS to 
start a new cycle.  This process is repeated until the desired chain 
length is reached. 
FASs of different organisms always are terminated to produce a 
long aliphatic linear saturated fatty acid.  Even though polyketides 
are biosynthesized through a mechanism similar to fatty acid 
biosynthesis, polyketide synthases (PKSs) produce many 
structurally diverse compounds (Figure I-1).  Polyketide 
biosynthesis differs from fatty acid formation in four aspects 
(Figure 11-2).1-3  (1) A PKS can sometimes use various building 
units, such as butyrate and other branched carboxylic acids. 5 
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Figure  1-2.  Biosynthetic mechanism of  fatty  acid  and 
polyketide  formation. 
(2) After each decarboxylative condensation, the f3-keto-group of 
the growing chain is not always processed in each cycle of the 
biosynthesis.  A new cycle may be initiated without further 6 
processing of the 0-ketone, and an acyl chain containing a 13-keto, 
a-hydroxyl,  a,a-olefin, or fully reduced a-carbon can be used by 
PKS to start a new cycle. (3) Since a PKS sometimes does not 
always completely process a 13-ketone before starting a new cycle, 
chiral centers may be introduced during the polyketide synthesis. 
Also, the presence of a side chain on the building unit may end 
with a chiral center. (4) PKS biosynthesis is accompanied by  other 
processes such as folding and cyclization by carbon-carbon bond 
formation, lactonization, or formation of an amide bond with an 
amino acid.  Because of this variation in starter and extender units, 
carbon chain length, substituent functionalization and 
stereochemistry,  the remarkable structurally  diverse polyketides 
can be generated in nature. 
Complex  Polyketides 
Plants have quite different PKSs from bacteria and fungi.  The 
PKSs of plants do not have ACP functionality and catalyze 
decarboxylative condensing reactions directly on the CoA ester of a 
carboxylic acid.1,2,10  Bacterial and fungal PKSs can be classified 
into two types.1-3  Type I PKSs are described as multifunctional 
enzyme complexes like Type I FAS, while Type II PKSs are 
multienzyme complexes like Type II PKS.  Type I PKSs are 
responsible for production of complex polyketides which  consist of 
polyketide skeletons more highly reduced than those of the poly-
a-keto intermediates in aromatic polyketide biosynthesis.  The 
polyketide-derived unit from complex PKSs can end with a linear 7 
chain (e.g. polyethers), a lactone (e.g. macrolides), or as a lactam 
(e.g. macrolactams). 
Feeding experiments for the biosynthesis of bacterial and fungal 
complex polyketides (i.e. macrolides and polyethers) showed that 
these pathways  involve a stepwise processive mechanism, in 
which the stereochemistry of the side chains and the appropriate 
degree of processing of the a-carbons are precisely processed into 
the acyl chain prior to subsequent elongation cycles.2,4,10  At 
each step,  the enzyme must determine the correct stereochemistry 
of the side chain and the degree and stereochemistry of processing 
of the 0-carbon. 
The application of molecular genetics to the biosynthetic 
pathways of complex polyketides by forward genetic approaches 
has yielded dramatic insights into the organization and function of 
these biosynthetic systems.  The cloning of biosynthetic genes for 
the macrolide portion for erythromycin, 6-deoxyerythronolide B, 
by Katz at Abbott Laboratories,11,12 and Lead lay at University of 
Cambridge ,13 was truly a landmark development.  The eryA gene 
for 6-deoxyerythronolide B biosynthesis is organized into three 
large (10 kb) open reading frames (ORFs) each containing a series 
of domains, with each of these responsible for one of the individual 
steps of polyketide chain assembly (Figure 1-3).  Each of the three 
ORFs encode a protein which possesses all of the required activities 
involved in two methylmalonate-propionate condensation cycles. 
Each condensation, with the appropriate reducing activities, was 
designated a module, each of which harbors the appropriate 
complement of ketosynthase (KS), ketoreductase (KR), dehydrase Module 2  Module 4  Module 6 Module 1  Module 3  Module 5 
1 
6-Deoxyerythronolide B 
Figure 1-3. Biosynthetic pathway for 6-deoxyerythromycin B. 6-Deoxyerythromycin 
B is the macrolide precursor of erythromycin. Open arrows represent ORFs. 
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(DH), enoylreductase (ER), acyl carrier protein (ACP) and 
acyltransferase (AT) domains, strongly reminiscent of an animal 
fatty acid synthase in both overall size and organization.  So, a total 
of six modules make up the entire 6-deoxyerythronolide B.  More 
recently, the PKS gene clusters for avernectin from Streptomyces 
avermitis,14 for FK506 from Streptomyces sp. MA6548,15 and a 
Bacillus subtilis gene of unknown function resembling ery  A,16 
have also been cloned and characterized.  The molecular genetic 
studies on those PKS genes showed that they are indeed 
multifunctional Type I PKSs, as expected. 
Aromatic  Polyketides 
Type II polyketide synthases, catalyzing the biosynthesis of 
aromatic polyketides, are multienzyme complexes like Type II FAS. 
Molecular genetic analysis of a number of PKS gene  clusters1-3 has 
revealed that each component of the PKS such as ketosynthase, 
ketoreductase, acyltransferase, dehydrase, acyl carrier protein,  etc. 
is tightly clustered with regulatory gene(s) and self-resistance 
gene(s) on a relatively small area of chromosomal DNA.  The 
actinorhodin PKS from Streptomyces coelicolor and tetracenomycin 
PKS from Streptomyces glaucesceus are the best known examples 
for aromatic PKSs.  The entire biosynthetic gene clusters for each of 
these molecules were cloned and completely  sequenced.17-25 
Actinorhodin is  biosynthesized by decarboxylative condensing 
reaction of eight acetate residues, while tetracenomycin is derived 
from ten acetate residues. 10
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Figure  1-4.  Organization of aromatic PKS gene clusters  in 
actinorhodin  (act) in Streptomyces  coelicolor;17,18 
tetracenomycin  (tcm) in S.  glaucescens;22- 24  granaticin 
(gra) in  S.  violaceoruber;7  oxytetracycline  (otc) in S. 
rimosus ;8  jadomycin (jad) in S.  venezuelae,9  urdamycin 
(urd) in S. fradiae.40  Open arrows represent ORFs.  KR, 
ketoreductase; OX, oxidase; CY, cyclase; HY, hydroxylase; MT, 
methyltransferase. 
Figure 4 illustrates the several PKS gene clusters that have been 
cloned and sequenced so far.  The PKS-encoding segments thus far 
characterized showed remarkable organizational similarity.  By 
complementation of actinorhodin blocked mutants of Streptomyces 
coelicolor with the cloned actinorhodin PKS genes, it was possible 
to partly understand the function of individual gene products  of 11
 
the PKS gene cluster.  The detailed functions and specificity of the 
individual ORFs were deciphered by the landmark works of 
Khoslar et al.26-32  They expressed cassettes of individual ORFs of 
actinorhodin and tetracenomycin PKS genes in Streptomyces 
coelicolor CH999, which is a PKS minus mutant.  From these 
researches, it was determined that ORF2 (chain length factor) 
controls the size of a hypothetical nascent poly-13-ketone 
intermediate made by the KS and ACP component and polyketide 
cyclases govern the folding and cyclization(s) of the nascent poly 
3- ketone  intermediate. 
A common feature of the organization of the sequenced aromatic 
PKS gene clusters is a group of three characteristic ORFs; ORF1-2-3. 
These ORFs are the so called 'minimal PKS genes' that perform the 
condensations of a specific acyl coenzyme A (CoA) starter unit with 
a specific varying number of malonyl-CoA extender  units, resulting 
a specific polyketide backbone.  ORF1 encodes both ketosynthase 
and acyltransferase activities, and contains an especially highly 
conserved GPXXXXXXXCXSXL motif.  This is present at the active 
site of both Type I and II PKSs, and provides the enzyme residue 
required for thioester linkage to the acyl chain.  ORF2 encodes a 
chain length determining factor.  The deduced protein sequences of 
ORF1-2 show particularly high similarity with the FabB condensing 
enzyme of E. coli Type II FAS. ORF3 polypeptides,  the acyl carrier 
proteins, are all less than 100 amino acids in length and contain 
the highly conserved DLXGYDS motif characteristic of the 4­
phosphopantotheine binding site of ACPs. 12
 
Biosynthetic  studies  on  aromatic  polyketides  from 
Streptomyces WP 4669, S.  murayamaensis, and S.  rimosus 
Kinamycins35 (3) from S.  murayamaensis,  with a 5­
diazobenzo[b]fluorene skeleton, are derived from an aromatic 
benz[a]anthraquinone  precursor,  dehydrorabelomycin (4).3 6 
The biosynthetic pathway of kinamycins (Figure II-1) was 
elucidated mostly by studies of isotope labeling and S. 
murayamaensis mutants which were defective in kinamycins 
synthesis.41  Dehydrorabelomycin derives from a single 
decaketide chain formed on the polyketide biosynthetic pathway. 
Enzymatic ring closure reactions of the hypothetical decaketide 
result in dehydrorabelomycin and are followed by a remarkable 
process of oxidation, ring opening, and ring contraction to  convert 
into kinamycins.  These unusual interconversion steps are  still 
under investigation.  S.  murayamaensis produces another  aromatic 
polyketide compound, the phenanthraquinone  murayaquinone 
(Figure II-2).3 8 
= 
OCH3 0  OH 
1, R=H  2  3 
4, R=OH 13
 
Tetrangulo133 (1) from S. rimosus  and PD 11674034 (2) from S. 
WP 4669 are aromatic benz[a]anthraquinone polyketide antibiotics. 
Because of the obvious structural similarity between PD 116740 
and dehydrorabelomycin, a study set out to establish the 
biosynthesis of PD 116740.42  Cultures of S. WP 4669 were 
supplemented with [1-1802] acetate.  This gave rise to PD 116740 
devoid of any oxygen-18 at C6.  Also cultures supplemented with 
[2,4,5,9,11] dehydrorabelomycin did not label the resultant PD 
116740 with deuterium.  However, when cultures were 
supplemented with [2,4-2H4] tetrangulol, deuterium was 
incorporated regiospecifically into H-2 and H-4 of PD 116740. 
These results clearly indicate that tetrangulol is the key 
intermediate in the biosynthesis of PD 116740 but is not a 
precursor to dehydrorabelomycin.  An enolization of the 
polyketide intermediate occurs to generate the C-6 oxygen of 
dehydrorabelomycin whereas a reduction-elimination sequence 
operates to generate tetrangulo1.37  Presumably the C-5,6 diol of 
PD 116740 arises after epoxidation and hydrolysis from 
tetrangulol. 
While the biosynthetic studies on tetrangulol, PD 116740, and 
kinamycins have elucidated the pathways that we know, it became 
clear that an understanding of the molecular biology of these 
pathways would be of great value. 14
 
Strategies  for  cloning  aromatic PKS biosynthetic  gene
clusters from S. WP 4669, S.  murayamaensis, and S.
rimosus 
Since polyketide assembly is always likely to involve similar 
biochemical processes and generate structurally related thioester 
intermediates, cloned DNA coding for one synthase may serve as a 
hybridization probe for the isolation of others.3 9  The actinorhodin 
biosynthetic genes of S.  coelicolor are the most widely used probes 
to identify other aromatic polyketide biosynthetic genes of 
Streptomyces  sp.  In an attempt to clone the polyketide 
biosynthetic genes of S.  murayamaensis, a genomic DNA library of 
S.  murayamaensis was constructed in EMBL4 bacteriophage prior 
to the work described in this thesis.  By screening the library with 
actinorhodin and granaticin biosynthetic genes, the 25 clones 
showing homology with either of the genes were identified.  EcoRI 
and BamHI restriction enzyme mapping of the clones showed that 
the 25 lambda clones might be grouped into several independent 
PKS gene clusters. 
The aim of my research  has been to clone the biosynthetic genes 
of kinamycin, tetrangulol, and PDII of S. murayamaensis, S. 
rimosus, and Streptomyces WP 4669, respectively.  Work began 
with the 25 clones from the bacteriophage S.  murayamaensis 
genomic DNA library.  The insert DNAs (15-20 kb) were subcloned 
into the Streptomyces low copy plasmid pIJ94143 or the 
Streptomyces-E.coli shuttle vector pKC121844 and then 
transformed into S.  lividans and S. parvulus.  However, no 
expression of metabolites identifiable with either the kinamycin or 15
 
murayaquinone pathways was observed from any of the S.  lividans 
or S.  parvulus transformants. 
Since typical aromatic polyketide biosynthetic gene clusters are 
roughly 22-34 kb long, we decided to clone much larger pieces of 
S.  murayamaensis DNA to improve the chances of expressing 
recognizable polyketide metabolites.  While constructing the new S. 
murayamaensis genomic DNA library in E. coli using the 
Streptomyces-E. coli shuttle cosmid vector pOJ446,44 genomic DNA 
libraries of S. rimosus and Streptomyces WP 4669 were prepared 
in the same manner.  By screening each of the cosmid libraries 
with a probe, actl -ORF1, the ketosynthase gene of the actinorhodin 
biosynthetic gene cluster, two PKS biosynthetic gene clusters from 
each of the three libraries were identified.  These cosmids were 
then used to transform S.  lividans.  Expression of identifiable 
metabolites was obtained from one gene cluster from each 
organism. 16
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Chapter  II 
Cloning two polyketide  biosynthetic gene 
clusters from a Streptomyces  murayamaensis 
bacteriophage  library 
Introduction 
Streptomycetes are  Gram-positive, pseudo-fungal prokaryotes 
that produce diverse secondary metabolites including antibiotics, 
chemotherapeutic agents, ionophores and immuno-modulators. 
Among the nearly 6000 antibiotics of natural origin that have been 
characterized, more than 60% are produced by members of the 
genus Streptomyces.1  Interestingly, most Streptomyces species 
produce more than one secondary metabolite. 
Streptomyces  murayamaensis is a typical example.  It has 
extremely complex secondary metabolism.  This organism produces 
a variety of aromatic polyketide structures, including 5­
diazobenzo[b]fluorenes  (kinamycins),2-4 a benz[a]anthraquinone 
(dehydrorabelomycin),5-7 phenanthraquinones  (murayaquinone8 
and murayalactone9) and 4-hydroxy-3-nitrosobenzamide,10 as 
well as metabolites based on aliphatic compounds 
(antimycins11,12). 
The kinamycins, broad-spectrum antibiotics with modest 
cytotoxicity, are produced from a polyketide pathway.5-7 24 
Biosynthetic studies conducted in our group on the kinamycins 
showed that they are derived from a single decaketide precursor 
(Figure II-1).  Murayaquinone, having antibacterial activity against 
Mycoplasma galliseptia and Treponema hyodysenteriae, is derived 
from an independent decaketide pathway (Figure 11-2).1 1 
One of our group's major interests is to understand the 
biosynthetic pathway for the kinamycins.  Much of the present 
information about the pathway has been obtained from isotope 
labeling studies and by spectroscopic examination of the 
accumulated intermediate compounds from kinamycin mutants.2­
17  These traditional approaches have provided a detailed though 
incomplete outline of the biosynthetic pathway.  As a complement 
to available structural details, a molecular genetic approach is 
required to address questions pertaining to detailed functions and 
specificities of the polyketide synthases (PKS). 
In order to begin studying the molecular biology of the S. 
murayamaensis polyketide pathways, Professor Gould constructed 
a S. murayamaensis genomic DNA library in EMBL4 (At) 
bacteriophage.  The bacteriophage library of S.  murayamaensis has 
roughly 15 to 20 kb DNA inserts.  Plaque lifts representing about 
8,000 X. clones were screened with probes made from gra ORF1, the 
DNA region encoding the ketosynthase gene of the granaticin 
biosynthetic gene cluster,37 and with actIll, the ketoreductase 
gene from the actinorhodin biosynthetic PKS gene  cluster.21 A 
total of 22 clones were tentatively identified as hybridizing with 
one or both of the probes.  I started to work with these 22 clones 
to transfer the inserts into Streptomyces plasmid  p1.194118  or 25
 
Streptomyces-E.  coli shuttle vector pKC1218.1 9  These subclones 
were then to be transformed into S.  lividans and S.  parvulus for 
expression testing.  S.  lividans is the most frequently used host in 
Streptomyces molecular genetics, but it has its own polyketide 
pathway (antinorhodin) and there was a possibility of 
unpredictable interactions.  S. parvulus does not have a polyketide 
pathway, but it is more difficult to work with.  It was hoped that 
the kinamycin PKS, and possibly the murayaquinone PKS, could be 
identified by expression of these metabolites or recognizable 
intermediates. 26 
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Figure  II-1.  Kinamycins  biosynthetic pathway  of  S. 
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Materials  and Methods 
Bacterial  strains  and  plasmids  used 
Streptomyces murayamaensis was a gift from Professors Omura 
(Kitasato University, Japan) and Hornemann (University of 
Wisconsin).  Streptomyces lividans TK24 and Streptomyces 
parvulus (ATCC # 12434), used as recombinant host strains, were 
obtained from the John Innes Institute (England) and ATCC, 
respectively.  E. coli LE392, used as a bacteriophage host, was 
kindly provided by Dr. C. Mathews (Oregon State University, USA). 
E. coli DH5a, used to propagate plasmids, was a gift from Dr. T. 
Dreher (Oregon State University, USA).  0.1941 and pKC1218, used 
as cloning vectors, were obtained from the John Innes Institute 
(England) and Lilly Research Laboratories, respectively. 
Bacteriophage DNA preparation  for  subcloning 
Lambda phage recovery.  Plating bacteria (E.  coli LE392) 
were prepared by culturing a single bacterial colony in L-broth (50 
mL)20 supplemented with 0.2% maltose in  a sterile 250 mL flask 
(37 0C, 250 rpm, overnight).  The bacteria were centrifuged at 
2300 rpm, 4 0C, 15 min, then resuspended in 10 mM MgSO4 (10 
mL).  The lambda phage clones prepared previously were diluted 
to a 10-7 dilution in SM  buffer.20  Lambda phages (50  111) from 
each dilution were mixed with the plating bacteria suspension (100 
111) in sterile 1.5 ml microcentrifuge tubes. After a 20 minute 
incubation at room temperature,  melted top agarose (3 ml, 48 0C) 29 
was poured directly into the mixture and the mixture was poured 
onto dried NZ agar20 in Petri-dish plates.  After overnight culture 
at 37 0C, well separated single plaques from an appropriate 
dilution were recovered in SM buffer (100 ill)  containing 
chloroform (0.3-0.5 111). 
Minilysate  preparation.  Phage mini-lysates were prepared 
by infecting 1/10-1/2 volume of the phage recovery suspension 
into an E. coli LE392 suspension (2-5  1.11) at 37 0C, 1 hour, followed 
by incubation in NZ broth (5 ml) for 20 min at room temperature, 
followed by 37 0C, 250 rpm overnight. 
Mini-prep of the phage DNAs.  After clear lysis was 
obtained, the phage were purified from the bacterial debris by low 
speed centrifugation (4000 x g, 20 min) after addition of 
chloroform (0.5% w/v). Then, solid PEG 8000 and NaC1 were added 
to a final concentration of 10% (w/v) and 1 M, respectively.  After 
overnight incubation at 4 0C, phage particles were sedimented by 
centrifugation (30 min, 4000 x g). The precipitate was dispersed in 
SM buffer (0.5 ml), and cellular DNA and RNA were removed by 
treatment with DNase I (1 i_tg.m1-1) and RNase A (10 .tg.m1-1) at 37 
0C for 30 min. Then, SDS (10% w/v), EDTA (0.25 M), and proteinase 
K (20 mg/ml) were added to final concentrations of 0.1% (w/v), 10 
mM and 0.1 mg.m1-1, respectively, and the mixture was incubated 
at 55 0C for 30 min. After two phenol/chloroform extractions, DNA 
was recovered by precipitation with 0.3 M sodium acetate (pH 7.0) 
and 2.5 volumes of ethanol. Typically, about 20 jig of phage DNA 
was obtained from a 5 ml culture. 30
 
Maxi-Lysates  for  phage  preparation.  Phage preparations 
were made by infecting  exponentially growing cultures of E. coli 
LE392 in 200 ml NZCYM20 (OD600 =0.5) with mini-lysate (2.5 mL). 
The growth was followed spectrophotometrically.  When the OD600 
dropped to 0.6-0.7, the lysis was completed by addition of CHC13 
(0.5 ml). After  further incubation (10 min, 37 0C), the lysate was 
treated with NaC1 (8g). DNase and RNase (to 1 µg /ml) were added 
to the lysate  to remove bacterial DNA and RNA.  After further 
incubation (1  hour), the supernatant was collected by 
centrifugation (10 min, 4 0C, 14,000 x g). The supernatant  was 
treated with PEG 8000 (20 g)  and stored overnight at 4 °C. The 
precipitated phage were  recovered in SM buffer (10 ml) after 
centrifugation (10 min, 10,000 rpm, 4 0C). The phage were further 
purified by collecting the phage particles by centrifugation (25,000 
rpm, 2 hours, 4 0C) in a Beckman SW41 rotor.  After removing the 
supernatant, SM buffer (1 ml) was added to the glassy pellet of 
bacteriophage particles and left overnight. 
DNA preparation. Phage particles were collected in 10 mM 
Tris-HC1, 20 mM EDTA, pH 8.0, (3-5 ml) in 17x100 mm Falcon 
tubes (Falcon #2002). Then, proteinase K (20 mg/ml) and SDS (10% 
w/v) were added to final concentrations of 0.5 mg/ml and 0.5% 
w/v, respectively.  After 1 hour at  55 0C, the DNA was extracted 
with phenol/chloroform and dissolved in TE 8 buffer (400-500 p.1). 
Subcloning  S.  murayamaensis PKS gene inserts  into 
pIJ941 
pIJ941  preparation  for  subcloning. 31
 
pIJ941  extraction.  Spore suspensions (0.2 ml) of S.  lividans 
TK24 containing pIJ941 were used to inoculate four 2 L flasks 
containing YEME (500 ml) supplemented with 0.5% glycine.  Each 
flask was baffled with a stainless steel spring in order to improve 
aeration and prevent clumping of mycelia.  Cultures were grown 
for three days at 30 0C with vigorous shaking (250 rpm).  The S. 
lividans mycelia were collected by centrifugation (2500 X g, 15 
min) in a Beckman table top centrifuge.  The mycelia from each 
flask (2-5 g) were resuspended in 25 ml TEG (50 mM glucose, 10 
mM EDTA pH 8.0, 25 mM Tris pH 8.0).  After treating with 
lysozyme (50 mg) and RNase (25 ml of a 5 mg/ml) for 10-30 min 
at room temperature, the mycelia were lysed by addition of 0.2 M 
Na0H/1% SDS (50 ml) followed by incubation at room temperature 
for 30 min.  The mixtures were then treated with 3M NaOAc, pH 
4.8 (40 ml) and acid phenol/chloroform (5 ml), and then kept on 
ice for 30 min.  After removing the precipitate by centrifugation 
(10,000 x g, 10 min), an equal volume of isopropanol was added to 
the supernatant.  After a 30 min incubation on ice, the DNA 
precipitate was recovered in TE (10 ml) by centrifugation (10,000 
x g, 10 min).  The protein contaminant was removed by 
phenol/chloroform extraction.  DNA was recovered once again in TE 
buffer (7 ml) after isopropanol precipitation. 
pIJ941  purification.  The extracted pIJ941 was purified by a 
standard CsC1 ultracentrifugation method.20 
Preparation  of  S.  lividans and S.  parvulus  protoplasts  for 
transformation 32
 
S.  lividans and S. parvulus  were propergated on a R2YE 
medium. The spore suspensions of the Streptomyces were 
prepared by scraping the surface of a sporulating agar culture as 
described in the Streptomyces Lab Mannual.18 Cultures of S. 
lividans or S. parvulus (50 ml) were grown for 40 hours from a 
spore suspension (0.2 ml) in YEME medium + 0.5% glycine (S. 
lividans) or 1.0% glycine (S. parvulus) at 30 0C, 250 rpm in an 
orbital shaker.  Each culture was divided in half and centrifuged in 
two universal bottles (3000 rpm, 20 min) in a Wifuge desktop 
centrifuge.  The mycelia were collected for protoplast preparations 
as discussed in the Streptomyces Lab  Manual.18 For S. parvulus 
protoplast preparation, 2 mg/ml of lysozyme solution was used 
instead of 1 mg/ml of lysozyme solution. After making protoplasts, 
the number of protoplasts were counted by a hemacytometer. 5 X 
108 protoplasts were devided into each 1.5 ml microcentrifuge 
tubes. 
Preparation  of  S.  lividans  transformants  with  recombinant 
plasmids 
Preparation of S.  murayamaensis DNA  insert.  Lambda 
phage DNAs (20 gl from 3-4 ggigl stock) were diluted up to 200 gl 
and kept several days in a cold room to be completely dispersed. 
The diluted phage DNAs (200 gl) were digested for 2 minutes with 
EcoRI (20 units) at 37 0C. S. murayamaensis DNA inserts were then 
separated by 0.6 %  agarose gel electrophoresis and purified by 
Sephaglass BP (Pharmacia Co.) by manufacturer's suggestion. 
Ligation of S.  murayamaensis DNA fragment with 
pIJ941. The ligation mixtures (10 gl) were composed of the 33
 
dephosphorylated pIJ941 (0.2-0.3  lig), S.  murayamaensis DNA 
insert (0.05-0.1 lig),  T4 ligase (1 41,  1 Weiss unit) to react 
overnight at 16 °C.  The completion of the ligation reaction was 
confirmed by 0.6% agarose gel electrophoresis. 
Transformation  of  S.  lividans  with  the  recombinant 
pIJ941.  An aliquot (2 1.11) from the ligation mixture (30 ill) was 
applied to S.  lividans  protoplasts (5 x 108) in P-buffer (50 pi) to 
be transformed by using T buffer (detailed procedure in Hopwood 
Streptomyces Lab Manual).18  The transformants were detected 
by overlaying soft nutrient agar (2.5 ml) containing thiostrepton 
(500 lig/m1) per plate 14-20 hours later.  Transformants that were 
both thiostrepton resistant and hygromycin sensitive  were 
selected18 and then transformants were spread onto fresh R2YE 
agar plates containing 50 gg/m1 thiostrepton for confluent growth. 
Spore suspensions were prepared from the agar plates 2-4 weeks 
later by the standard method.1 8 
Analysis of the S.  lividans transformants.  Each  spore 
suspension (0.1 ml) of thiostrepton resistant, hygromycin sensitive 
S.  lividans transformants was inoculated into YEME (50 ml) 
supplemented with glycine (0.5 %) and thiostrepton (5 1.1g/m1) in a 
50 ml flask baffled with a stainless steel spring.  Cultures were 
grown for three days at 30 0C with vigorous shaking (250 rpm). 
The mycelia were harvested by centrifugation (2500 x g, 10 min) 
and washed with sucrose (10.3%) prior to storage at -20 °C.  The 
frozen mycelia were thawed at room temperature and 
resuspended in 4 ml of lysozyme solution (25 mM Tris-HC1 (pH 8), 
25 mM EDTA (pH 8), 0.3 M sucrose, 2 mg /ml lysozyme, and 2.5 34 
mg/ml RNase) followed by incubation for 15 min at room 
temperature. The mycelia were completely lysed by adding 0.3 M 
NaOH /2% SDS followed by incubation at room temperature for 10 
min.  The mixture was treated with 3 M sodium acetate (4 ml, pH 
4.8) and left on ice for 15 min.  After removal of the precipitate by 
centrifugation (3000 x g, 15 min) in a Beckman table top 
centrifuge, an equal volume of isopropanol was added to the 
supernatant.  After incubating the mixture on ice for 30 min, the 
precipitated plasmid was recovered  by centrifugation (3000 x g, 
15 min) in a Beckman table top centrifuge and  resuspended in 0.8 
ml TE.  The plasmid was further purified using Pharmacia Magic 
Plasmid Prep Kit (Pharmacia, Madison, Wisconsin). The typical 
yield of the plasmid was 3-5 lig/50 0. 
Transformation  of  S.  parvulus. 
Aliquots (2 gl) from the S.  lividans plasmid preps were applied 
to S. parvulus  protoplasts (5 x 108) in 50 µl P buffer and 
transformed using the T buffer (detailed procedure in Hopwood 
Streptomyces Lab Manual).18  Transformants were detected by 
overlaying with 2.5 ml of soft nutrient agar (containing 500 µg /ml 
thiostrepton) per plate 14-20 hours after incubation.  Thiostrepton 
resistant transformants were selected, and spore suspensions were 
prepared from single colonies. 
Subcloning  S.  murayamaensis PKS gene inserts  into 
pKC1218 35 
Preparation  of  S.  murayamaensis PKS gene inserts from 
Eco RI digested phage DNA.  Aliquots (10 p.1) of the original 
phage stocks (1-2 pg/gg) were diluted to 495 pl with a mixture 
consisting of Eco RI buffer (50 gl) and ddH2O (435 p.1).  After 
incubation at 4 0C for several hours to completely disperse the 
phage DNA, Eco RI (50 units) was added. The mixture was 
incubated at 37 0C for 5 min for partial digestion (e.g. clone 14a) 
and for 3 hours for complete digestion.  The digested phage DNA 
was extracted one time each with phenol/CHC13 (pH 8.0) and with 
CHC13. The CHC13 was removed from the DNA solution using a 
Microcon-100 microconcentrator (Amicon Co.). 
Ligation of the  S.  murayamaensis inserts  into 
dephosphorylated  pKC1218.  Ligations of the digested phage 
DNAs into dephosphorylated pKC1218 were achieved by a two-
step ligation.  First, the digested phage DNAs (2-5 lig) were mixed 
with  the dephosphorylated pKC1218 (0.8-2 p.g) in 9.5 p.1  ligation 
mixture containing  1  1.1.1 of T4 ligase buffer.  After adding T4 ligase 
(0.5 pl, 2.5 units, USB Co.), the ligation mixtures were incubated for 
30 min at 16 'DC.  In the second step, 90 p.1 of ligation dilution 
mixture (9 p.1 T4 ligase buffer, 1 pl T4 ligase, and 80 pl ddH2O) was 
added, and the ligation mixture was incubated overnight at 16 °C. 
Transformation of E. coli DH5a.  For each transformation 
reaction, a microcentrifuge tube containing E. coli DH5a competent 
cells was thawed in an ice-water bath.  A portion of the ligation 
mixture (8-10 gl) was added to the tube.  The tube was kept at 0 
0C for 40 min, placed in a 42 0C water bath for 90 seconds, kept 
again at 0 'DC for 2 min, diluted with 0.8 ml SOB20 and then 36
 
incubated for 1 hour at 37 °C.  Aliquots of the transformed E. coli 
were spread onto LB agar plates containing 100 µg /µl apramycin. 
Recombinant Plasmid  Screening.  White colonies carrying 
recombinant plasmids were inoculated into 2 ml of LB broth 
containing 15 µg /ml of apramycin in a loosely capped 15 ml 
culture tube.  The culture was incubated overnight at 37 0C, 280 
rpm.  Plasmid DNAs were isolated from 1.5 ml of the cultures 
according to standard procedures.20  Recombinant plasmids having 
the correct insert were confirmed by restriction enzyme digestion 
analyses. 
Transformation  of  S.  lividans with  isolated  recombinant 
plasmids. S.  lividans  protoplasts (5 x 108  in 50 µl P-buffer) 
were mixed with the 5 pl of the E. coli recombinant plasmid preps 
(0.01-0.1 µg /µl) by tapping the tube.  The protoplasts were 
transformed by adding 200 ill of T-Buffer as in the standard 
method.1 8 The transformants  were detected by overlaying 2.5 mL 
of soft nutrient agar (600 gg/m1 apramycin) per plate 14-20 hours 
later. 
Southern  hybridization  of  the  recombinant EMBL4 
bacteriophages 
Preparation  of  DNA-transferred  nylon  membrane. 
Recombinant EMBL4 phage clones (0.3-0.5 lig) completely 
digested with Barn HI were loaded into individual lanes of a 0.75 % 
agarose gel for overnight electrophoresis in 0.5 x TBE buffer at 35 
V.  After visualizing and photographing the DNA bands by UV light 
after staining with ethidium bromide, the DNA in the gels was 37 
denatured in 0.4 N NaOH/0.6 M NaC1 for 30 min incubation at room 
temperature with gentle agitation. The gels were neutralized by 
incubating in 1.5 M NaOH/0.5 M Tris-HC1, pH 7.5 for 30 min with 
gentle agitation.  The denatured DNA in the gel was transferred by 
capillary action onto a positively charged nylon membrane 
(Gene Screen Plus, Dupont Co.) in 10xSSC for 24 hours.  The 
transferred DNA on the nylon membrane was completely 
denatured by immersing in an excess of 0.4 N NaOH for 60 seconds. 
After rinsing with an excess of 0.2 M Tris-HC1, pH 7.5/2xSSC, the 
membrane was dried  at room temperature. 
Probe preparation.  10 ng of actl -ORFI (ketosynthase gene of 
actinorhodin biosynthesis) or actIII (ketoreductase gene of 
actinorhodin biosynthesis) were labeled with 10-25 1.1Ci of 
[a32PRIATP using  a Random Primed DNA labeling Kit from 
Boehringer Mannheim Co. for 1 hour at 37 °C.  The unincorporated 
[a32PRIATP was removed by dialysis several times through a 
Microcon-30 concentrator (Amicon Co.) 
Hybridization with the probe.  Prehybridization was  carried 
out in 10 ml of 1 % SDS/1 M NaC1/10 % dextran sulfate  and 1 mg 
of fragmented salmon sperm DNA in a hybridization oven at 65 °C. 
After several hours of prehybridization,  the radiolabeled probe 
was denatured by boiling and rapidly cooling on ice and then 
added to the mixture. Incubation was continued overnight at 65 °C. 
Washing  the membrane and  preparation  of X-ray  film. 
After hybridization, the membrane was washed two times with 
2xSSC/1 % SDS at 65 0C and then placed on Kodak X-ray film for 
40-44 hours at -80 °C.  The detailed washing procedures for the 38
 
hybridized membranes were followed by the manufacturer's 
instructions. 
Expression  testing  of  S.  lividans  and S.  parvulus
transform ants 
Fermentation  of  S.  lividans  and S.  parvulus 
transformants.  An S.  lividans  or S.  parvulus spore suspension 
(0.1 ml) was inoculated into 5 ml of YEME containing 6 1.1g/m1 of 
apramycin for transformants containing pKC1218-derived 
recombinant plasmids or 10 i.tg/m1 of thiostrepton for 
transformants  containing pIJ941-derived recombinant plasmids. 
After incubation for 3-4 days at 28 0C, 260 rpm, 0.25 ml of the 
seed culture was used to inoculate 5 ml of three production media; 
GPS,35 glycerol-asparagine,36 and YEME18 containing appropriate 
antibiotics in 18 ml culture tubes.  The rest of the cultures were 
used for plasmid mini-preps to confirm the presence of the correct 
plasmids.  All cultures were incubated at 28 'DC in a LabLine Rotary 
Incubator-Shaker at 300 rpm for 5 and 9 days. 
Analysis  of  the  transformant  metabolites.  The cultures 
were acidified (pH 2.5-3.0) with 0.1 N HC1, extracted with EtOAc, 
and the extracts dried using a SpeedVac centrifuge. The dried 
extracts were taken up in 100 41 of 10 % Me0H/CH2C12. An 
aliquot (10 0) of each extract was analyzed by reverse phase 
HPLC.  The metabolites were separated on a Waters NovaPak Cl 8 
radial compression column (0.8 x 10 cm) using a gradient of 5-95% 
acetonitrile in water over period of 30 min at 1.5 ml/min. 
Detection was by photodiode array. 39 
Other  Molecular  biological  techniques 
Plasmid DNA isolations from E. coli and preparation of E. coli 
competent cells were performed according to standard 
procedures.20  Restriction enzymes, DNA ligase and calf intestinal 
alkaline phosphatase (CIP) were purchased from Gibco BRL, New 
England Biolabs, United States Biochemical (USB), Promega and 
Boehringer Mannheim Co. and used according to the 
manufacturers'  instructions. 40
 
Results  and Discussion
 
Southern  hybridization  of  the lambda clones  with  actI­
ORF1 and actIII 
actl -ORFI (ketosynthase) and actIll (ketoreductase) probes 
derived from actinorhodin biosynthetic genes were hybridized 
separately at moderate stringency to Southern blots of a BamHI 
restriction digest of each of the lambda DNAs.  In the experiment 
using actl -ORFI, the probe hybridized strongly with the 6A1, 10a, 
13a, 14a, and 17a clones, moderately with the 1B1, 2A1, 4A1, 5B1, 
7c, and 15b clones, and weakly with the rest of the clones (Figure 
11-3).  Using actIll, strong hybridization was observed for the 10a, 
13a, and 14a clones (Figure 11-4).  1B1, 1B2, 2A1, 2B1, 3B1, 5B2, 
and 18A2 did not hybridize with act!!! and the rest of the clones 
hybridized very weakly with the probe. 
The act!!! gene encodes the C-9 ketoreductase, which catalyzes 
the reduction of the keto group to the corresponding secondary 
alcohol at C-9, counting from the carboxy terminus of the 
assembled polyketide.21,22  Recently, ketoreduction at the C-9 
position by act!!! was further confirmed by engineered 
biosynthesis of novel compounds produced by expressing a 
combination of individual genes of the actinorhodin and 
tetracenomycin PKS gene clusters.23,24 The actIII gene product 
catalyzes reduction of the C-9 carbonyl of any length nascent 
polyketide backbone studied so far, and the derived hydroxyl 1 2 3 4  5 6
  7  9 10  11  12  13  14 15 16  17 18 19 20 21 22 23 24 25
 
Figure  11-3.  Southern hybridization  of BamHI digested  S.  murayamaensis  lambda 
clones with actl -ORF1.  Lanes: 1, 1B1; 2, 1B2; 3, 2A1; 4, 2B1; 5, 3B1; 6, 4A1; 7, 4A2; 8, 5A2; 9, 
5B1; 10, 5B2; 11, 6A1; 12, 7a; 13, 7c; 14, 8A2; 15, 8B1; 16, 9c; 17, 10a; 18, 13a; 19, 14a; 20, 15b; 
21, 15d; 22, 17a; 23, 18A1; 24, 18A2; 25, 19B1.  Washing; 2x SSC/1% SDS. 1  2  3  4  5  6  7  8  9 10  11  12  13 14  15 16  17 18 19 20 21 22 23 24
  25 
Figure  11-4.  Southern  hybridization  of BamH1 digested  S.  murayamaensis  lambda
 
clones with actIII.  Lanes: 1, 1B1; 2, 1B2; 3, 2A1; 4, 2B1; 5, 3B1; 6,  4A1;  7,  4A2;  8,  5A2;  9, 5B1;
 
10, 5B2; 11, 6A1; 12, 7a; 13, 7c; 14, 8A2; 15, 8B1; 16, 9c; 17, 10a; 18,  13a;  19,  14a;  20,  15b;  21,
 
15d; 22, 17a; 23, 18A1; 24, 18A2; 25, 19B1.  Washing; 2x SSC/1% SDS.
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I 
group at C-9 is eliminated by subsequent aromatase action.  The 
kinamycin antibiotics, which are 5-diazobenz[b]fluorenes,  are 
biosynthesized from a polyketide origin through an intermediate 
benz[a]anthraquinone, dehydrorabelomycin, which does not have 
an oxygen function at the C-9 position.4,6,7,11  Thus, its PKS gene 
cluster should contain an actin homologue. 
IS  IS IS  Is  Is 
13a 
Is is  Is is is Is  Is Is  Is 
14a 
B  B  B BE 
10a 
14 kbp  8.2 kbp  6kbp 
Figure  11-5.  Restriction map of lambda clones  10a,  13a, 
and 14a.  The shaded area represents 5.6 kb Barn HI fragment 
which has been sequenced.3 1  The number of Sall sites on the left 
end of map could not be counted exactly because  so many Sall 
sites  generated the same size of small DNA fragments. 
Abbreviations for restriction endonuclease sites: B, BamHI; E, EcoRI; 
S, Sall. 
Restriction enzyme digest analysis showed that the 13a and 14a 
clones overlapped and there was tentative evidence that clone 10a 
might also do so (Figure 11-5).  These 3 clones were believed to be 44 
the most strong candidates for the kinamycin PKS gene cluster, 
since the clones hybridized strongly with both the ketosynthase 
(actl -ORFI and gra-ORF1) and ketoreductase (actIll) genes. 
A 5.6 kb BamHI fragment of clone 10a which hybridized with 
genes for ketosynthase (actl -ORF1 and gra-ORF1) and 
ketoreductase  (actIll) was subcloned and the entire region was 
sequenced.31 The insert was found to contain five complete open 
reading frames which showed high sequence similarity with genes 
from other aromatic polyketide pathways encoding ketosynthase 
(KS), chain length factor (CLF), an acyl carrier protein (ACP), a 
ketoreductase (KR), and a cyclase (CYC) (Figure 11-6).  The deduced 
amino acid sequence also contained several key active site residues 
from polyketide synthase genes. 
Barn HI  Barn HI 
I 
0  ( X 1000 ) 
PKS 1  PKS 2  ACP  KR  Cyclase
80% ident.  72% ident.  64% ident. 75% ident.  62% ident.
 
fren. KS1  fren. KS2  gran. ACP  akn. KR  fren. CYC
 
Figure  11-6.  Organization of the sequenced 5.6 kb BamHI 
fragment.  Abbreviations: fren, frenolicin; gran, granaticin; akn, 
alkavinone. 45
 
Preparation  of  recombinant  phage DNAs 
Recombinant phage having the putative PKS gene cluster inserts 
of S.  murayamaensis were prepared as described in the 
experimental section.  The phage were purified by precipitation in 
an ultracentrifuge.  Phage DNAs were prepared by extraction with 
phenol/CHC13 after removal of protein coats with proteinase K. 
These were then cut with EcoRI and analyzed by gel 
electrophoresis.  This restriction enzyme was only one that would 
cut at the vector/insert boundary.  Unfortunately, many of the 
insert DNAs were found to also contain EcoRI sites.  The results are 
summarized in Table II-1. 
Table  II-1.  The result  of the recombinant phage DNA
preparation. 
Eco RI sites in  insert  Recombinant phage clones 
zero  1B2,  2A1, 3B1, 5B1, 7a, 15b, 17a, 19B1 
one  2B1,  4A1, 4A2, 5B2, 6A1, 7c, 8A2, 10a, 
13a,  14a, 15d 
two  1B1, 4A2, 9c, 18A1, 18A2 
three  5A2 46
 
Subcloning  lambda  clones 
Subclonings were initially focused on  the clones having no 
internal EcoRI sites or showing strong hybridization to both 
probes, except the 10a clone which was studied by another 
member of the group.  Intact inserts from these clones were 
obtained by EcoRI digestion and purified fragments were inserted 
into a very low copy number Streptomyces plasmid, pIJ941 (Table 
11-2).  This proved to be very time-consuming.  Streptomyces 
grow very slowly, requiring more than  1 week on agar media, 
compared to overnight growth of E. coli.  Also, endogenous 
endonuclease activities and the thick cell wall of S.  lividans 
frequently resulted in plasmid preparations of poor yield and 
quality compared to E. coli.  After the 6 clones lacking an internal 
EcoRI site were successfully subcloned into pIJ941, a new 
Streptomyces-E. coli shuttle vector, pKC1218, became available.1 9 
This shuttle vector has many advantages over pIJ941, because 
preparation of recombinant plasmids is much easier in E. coli than 
in Streptomyces.  The remaining two clones with no internal EcoRI 
sites and clone 14a with one internal EcoRI site were cloned into 
this  shuttle vector. 
The EcoRI site was the only restriction enzyme site available for 
removing the inserts from the lambda clones.  Unfortunately, clone 
14a, which hybridized very strongly to both probes, had one EcoRI 
site within the S.  murayamaensis DNA insert.  The subcloning work 
was hampered by a very low yield of the insert after  partial Table  11-2  Bacterophages  and  plasmids  used  and  constructed  for  expression  tests
 
Phages 
plamids 
or  Relevant  Characteristic  (s)  Source 
Ph ages 
EMBL4  Derivative  of lambda, bacteriophage  vector  John  Innes 
Institute 
1B2 
2A1 
3B1 
5B1 
7a 
15b 
17a 
19B1 
14a 
PI as m ids 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
EMBL4 
containing 
containing 
containing 
containing 
containing 
containing 
containing 
containing 
containing 
15.5 kbp 
16.0 kbp 
18.2 kbp 
19.0 kbp 
18.3 kbp 
17.1 kbp 
16.8 kbp 
17.5 kbp 
18.0 kbp 
insert 
insert 
insert 
insert 
insert 
insert 
insert 
insert 
insert 
of 
of 
of 
of 
of 
of 
of 
of 
of 
S. 
S. 
S. 
S. 
S. 
S. 
S. 
S. 
S. 
murayamensis 
murayamensis 
murayomensis 
murayamensis 
murayamensis 
murayamensis 
muravamensis 
marayamensis 
muravamensis 
putative 
putative 
putative 
putative 
putative 
putative 
putative 
putative 
putative 
PKS 
PKS 
PKS 
PKS 
PKS 
PKS 
PKS 
PKS 
PKS 
genes 
genes 
genes 
genes 
genes 
genes 
genes 
genes 
genes 
This work 
This work 
This work 
This work 
This work 
This  work 
This work 
This  work 
This work 
pIJ941  25.0 kbp; Hygr, Thior Streptomyces  very low  copy  number plasmid  John  Innes 
Institute 
pKC1218 
pSH100 
pSH110 
pSH120 
pSH130 
pSH140 
pSH150 
pSH210 
5.8 kbp; E.  coli-Streptomyces Shuttle plasmid having pUC and Scp2*
pIJ941 with 15.5 kbp Eco RI subclone from phage 1B2 
pIJ941 with 18.2 kbp Eco RI subclone from phage 3B I 
pIJ941 with 19.0 kbp Eco RI subclone from phage 5131 
pIJ941 with  18.3 kbp Eco RI subclone from phage 7a 
pIJ941 with 17.1 kbp Eco RI subclone from phage 15b
pIJ941 with 16.8 kbp Eco RI subclone from phage 17a 
pKC1218 with 16.0 kbp Eco RI subclone from phage 2A1 
replicons  Eli Lilly Co. 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
pSH220 
pSH230 
pKC1218 with 17.5 kbp Eco RI subclone from phage 19B1 
pKC1218 with 15.5 kbp Eco RI subclone from phage 14a 
This work 
This work 48 
digestion and by very low efficiency for the ligation of such  a big 
insert into a plasmid. 
Since the plasmid pKC1218 does not easily accept big pieces of 
foreign DNA, we developed an efficient ligation protocol by using  a 
two-step ligation method.25 Ligation of one end of DNA to another 
can be regarded as a bimolecular reaction whose velocity under 
standard conditions is determined solely by the concentration of 
compatible DNA termini.  This is true no matter whether the 
termini are located on the same molecule of DNA (intramolecular 
ligation) or on different molecules (intermolecular ligation).20  In 
principle, at low concentration of DNA, recircularization of the 
plasmid DNA will occur with high efficiency.  If the concentration 
of DNA in the ligation reaction is increased, a given end of DNA is 
more likely to encounter a terminus located on another molecule 
before intramolecular ligation occurs.  At high DNA concentrations, 
therefore, the initial products of ligation will be dimers and larger 
oligomers.  As carried out, a very high DNA concentration (1-3 
Rg/1.11) of the digested phage DNA and the dephosphorylated 
plasmid was first prepared in 9.5 pl of ligation mixture.  After 
adding 0.5 p.1 of T4 ligase, the ligation mixtures were incubated for 
30 min at 16 0C to activate intermolecular ligation.  At this step, 
the very concentrated DNA fragments should prefer intermolecular 
ligation.  Second, 90 [11 of ligation dilution mixture (9 p1 T4 ligase 
buffer,  1 pl T4 ligase and 80 pl ddH2O) was then added and the 
ligation mixture incubated overnight at 16 °C.  In the second 
ligation step, the dimerized DNA fragment will prefer 
intramolecular ligation due to the low concentration of DNA. 49 
Clone 14a was partially digested with EcoRI and subcloned into 
pKC1218 by this direct two-step ligation method.  Generally, this 
method was found to be much more efficient in subcloning big 
inserts (<10 kb) than conventional single step ligation, and the two 
lambda clones (2A1 and 19B1) were also subcloned into pKC1218 
by the two-step method. 
Expression  test  of  transformants 
Streptomyces plasmid pIJ941 having the Scp2* replicon3 4 
propagates in a wide range of Streptomyces hosts, including S. 
lividans and S. parvulus.  However, the transformation efficiency of 
S. parvulus with pIJ941 was 100-1000 times lower than with S. 
lividans.  The low transformation efficiency of S. parvulus seems to 
be attributable to the restriction system of the organism rather 
than to cell membrane characteristics.  S.  parvulus protoplasts 
showed exactly the same microscopic morphology and same degree 
of sensitivity to SDS as S.  lividans protoplasts.  The pKC1218 vector 
has only part of the Scp2* replicon19 and does not have thepar 
gene, which is required to stably propagate the plasmid in the host. 
The pKC1218 and pKC1218-derived plasmids were able to 
transform only S.  lividans.  These plasmids were not able to 
transform S.  parvulus, which made this latter organism unsuitable 
for expression testing.  It appears that the entire Scp2* replicon is 
essential to propagate pKC1218 in S. parvulus. 
After confirming the presence of the recombinant plasmids in S. 
lividans and S.  parvulus transformants, the transformants were 50 
cultured in 3 different production media: GPS,35 YEME,18 and 
Glycerol- Asparagine (Gly-Asn)36 and then screened for new 
metabolite production.  Each medium has different characteristics. 
The Gly-Asn medium is a minimal media and is good for 
production of any secondary metabolites formed in a very nutrient 
poor condition or in a very late stage of stationary phase of a 
Streptomyces growth curve.  The YEME medium contains a large 
quantity of carbon source (sucrose) and is good for production of 
secondary metabolites formed in a nutrient rich condition or in an 
early stage of stationary phase.  The GPS is a nutrient rich medium 
and is good for production of a wide variety of different secondary 
metabolites at both early and late stages of the stationary phase. 
The metabolites of the transformants were extracted from each 
of the production cultures with ethyl acetate and analyzed by 
reverse phase HPLC with photodiode array detection.  The fact that 
a compound's retention time matches that of a standard compound 
under a given set of HPLC conditions is not by itself a sufficient 
criterion for identification of compounds.  The use of the 
photodiode array detector provides a UV-Visible spectrum of each 
peak in an HPLC chromatogram.  The UV-Visible spectrum depends 
on the chemical structure of compound.  So demonstrating that 
both the retention time and the UV-Visible spectrum of a 
compound match a standard would be a strong preliminary 
evidence for structural assignment of metabolites from the 
transformants. 
The production media of transformants carrying a recombinant 
plasmid were sometimes different colors than fermentation of S. 51 
lividans or S. parvulus carrying the vector alone.  However, HPLC 
analysis showed there were no obvious new peaks in any of the 
transformants, except for one S.  lividans transformant, S. 
lividansIpSH210 (Figure 11-7). 
The size of complete aromatic polyketide biosynthetic gene 
clusters examined to date have been shown to be 22-34 kbp.2 6 2 8 
The total size of the bacteriophage inserts which were subcloned 
for expression tests in this portion of the work was 15-20 kb, 
which is too small to contain an entire PKS gene cluster.  While it 
was possible that an intermediate compound, such as 
dehydrorabelomycin, might have been produced even by DNA 
regions smaller than an entire PKS cluster, this appeared not to be 
occurring. 
For the pSH210 transformants in the GPS production medium, 
new metabolites were recognized by HPLC (Figure 11-7 and 11-8). 
Although most metabolites did not match any of the metabolites 
produced by S.  lividans, they also did not match any known 
metabolites from S.  murayamaensis.  These metabolites was 
suspected to be stress metabolites of S.  lividans host.  Under 
normal fermentation conditions, these compounds were never 
observed from S.  livians.  Later, it was found that these 
metabolites were repeatedly produced from other S.  lividans 
transformants having an unstable plasmid.  The instability of some 
recombinant plasmids may come from intramolecular or 
intermolecular recombination of the plasmids.32 '33  Especially in 
the case of big inserts, such as cosmid clones, many  plasmids were 
not stable (Chapter III). 52 
PKS gene clusters of Streptomyces sp. usually consist of the 
biosynthetic genes and associated regulatory and self resistance 
genes.  All of the PKS gene clusters studied to date have proven to 
be tightly clustered in one region of the chromosome.  The DNA 
fragments compromising a part of PKS gene clusters may express 
intermediate compounds in a  heterologous host such as in case of 
daunorubicin9 and tetracenomycin.10  However, the identification 
of the PKS genes obtained from S.  murayamaensis by expression in 
heterologous hosts was not successful, probably because the S. 
murayamaensis PKS inserts (15-20 kb) were too small even for 
expression of intermediate compounds,  Identification of the genes 
by other ways such as gene disruption or rescuing mutants is 
laborious and time-consuming, and ambiguous results11-12 have 
often been obtained.  So, an S.  murayamaensis genomic DNA 
library containing much larger pieces of DNA was constructed in a 
cosmid vector, pOJ446, (Chapter III) to improve the chances of 
expressing recognizable polyketide metabolites. .43 
53 
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Chapter  III 
Cloning two PKS gene clusters from 
S.  murayamaensis and identification 
of  a  putative  kinamycin  biosynthetic  gene  cluster 
Introduction 
S.  murayamaensis is known to have at least two independent 
aromatic polyketide biosynthetic pathways which give rise to the 
distinct structural classes represented by kinamycins 1  (1) and by 
murayaquinone2 (2). 
OH 
2 1 
Kinamycin antibiotics are derived from the angucycline 
intermediate, dehydrorabelomycin (Figure  II-1).4  The ring folding 
processes during biosynthesis of the angucycline polyketide 61 
skeleton and for the murayaquinone polyketide 
phenanthraquinone skeleton are expected to be different from 
those for linear polycyclic compounds.  Cloning the kinamycins and 
murayaquinone PKS gene clusters may lead us to understand what 
causes the nascent polyketide backbones to adopt non-linear 
conformations and generate the angular skeletons of the 
angucycline and phenanthraquinone  structures. 
The kinamycin family of metabolites have been extensively 
studied in our group, and we are especially interested in the 
kinamycin biosynthetic gene cluster.  The region of the S. 
murayamaensis genome comprising the lambda clones 10,  13a, and 
14a (Figure 11-5) contains a 5.6 kbp BamHI fragment (Figure 11-6) 
which were initially identified because it hybridized strongly with 
both ketoreductase and ketosynthase genes.  It has recently been 
sequenced in our group, and was found to contain ACP and 
dehydrase/cyclase  genes,too.8  Attempts to knock out this PKS 
gene cluster with several of the sequenced ORFs by single 
crossover events in an effort to identify the product of this 
pathway. However the single crossover were unsuccessful, mainly 
because of the difficulty of introducing foreign DNA into S. 
murayamaensis. A double crossover disruption to knock out the 
ketoreductase gene of this cluster was then carried out.  The 
ketoreductase gene in S.  murayamaensis genome was apparently 
interrupted.  However, no detectable change was observed in the 
product profile of the S.  murayamaensis.  The attempt to identify 
the PKS gene clusters by expression in heterologous hosts was not 
also successful (Chapter II). 62 
The total size of biosynthetic gene clusters in Streptomyces for 
aromatic polyketide compounds have been  22-34 kbp.5-7 A new 
approach was undertaken to find the kinamycin and 
murayaquinone gene clusters.  Larger pieces of DNA (30-45 kbp) 
from S.  murayamaensis were cloned by using the cosmid vector, 
p0J446, constructed with dual replication origins for propagation in 
Streptomyces and E. coli  (Figure III-1).13  Clones containing PKS 
genes were again identified by hybridization with actl -ORF1.  The 
positive clones were then used for expression experiments to 
identify the product of each PKS gene cluster. 
SCP2* 
rep 
Xba I 
R  Eco RI 
Am  Barn HI 
p0J446 (10.4 kbp)  Spe I 
cos 
p rep 
cos 
Hpa I 
Figure  III-1  Cosmid cloning  vector used  to  prepare  a 
library of S.  murayamaensis genomic DNA. 63
 
Materials  and Methods 
Bacterial  strains  and plasmids  used.  The strain of 
Streptomyces murayamaensis was a gift from Professors Omura 
(Kitasato University, Japan) and Hornemann (University of 
Wisconsin).  Streptomyces lividans TK24, used as a recombinant 
host strain, were obtained from John Innes Institute (England).  E. 
coli XL1-B1ueMR, used for propagation of cosmid pOJ446 was 
purchased from Stratagene Co.  The cosmid pOJ446, used  for a 
cosmid library construction, was obtained from Lilly Research 
Laboratories. 
S.  murayamaensis genomic DNA isolation.  Genomic DNA 
was prepared from S.  murayamaensis as follows: mycelia from a 
50 ml culture grown in YEME containing 0.5 % glycine were 
collected by centrifugation at 3000 x g.  After twice washing the 
pellet with 10.3 % sucrose, it was resuspended in 10 ml of a 
solution containing: 25 mM Tris (pH 8.0), 50 mM glucose, 10 mM 
EDTA (pH 8.0), 20 gg/m1 RNase, 10 mg/ml lysozyme and 10 mg/ml 
acromopeptidase (Sigma, catalog number; A-3547) and incubated 
5-10 minutes at room temperature.  After the cell walls were 
partially degraded, proteinase K was added up to 0.5 mg/ml and 
the mixture incubated at 50 0C overnight.  The DNA was extracted 
once with phenol (pH 8.0), once with phenol/CHC13, and once  with 
CHC13, then precipitated by adding 2 volumes of ethanol and 0.1 
volume of 3 M sodium acetate (pH 7.0).  The tube was kept at room 64 
temperature for 5-10 min while gently mixing.  The liquid was 
decanted carefully and the precipitated genomic DNA adhered to 
the wall of the tube.  The precipitated genomic DNA was washed 
one time with 70% ethanol, and then air-dried for10 min after 
inverting the tube.  The genomic DNA was dissolved in 3 ml TE. 
Southern  hybridization.  Southern blotting and hybridization 
methods were basically the same as described in the Materials and 
Methods section of Chapter II. 
Partial digestion of genomic DNA. A series of tubes 
containing 26 RI of genomic DNAs (1 gg/p.1) were each treated with 
3 R1 of Mbo I buffer for partial digestion tests.  After keeping in a 
cold room for at least several hours to completely disperse the 
genomic DNA, 1 Rl (2 unit/g1) of Mbol (10 times diluted stock) was 
added to each.  The mixtures were then incubated at 37 0C for 0, 1, 
2, 4, 8, 20, 40, and 60 min to find the condition which gave the 
best yield of DNA in the 30-40 kb size range.  The digested DNAs 
were examined by electrophoresis through a 0.3 % agarose gel 
poured on a 1 % agarose support.  After identifying the most 
suitable digestion time, a 10 fold larger scale partial digestion (300 
R1) was carried out. 
Ligation of genomic DNA to cosmid pOJ446. Mbol 
partially digested S. murayamaensis genomic DNA (10-20 14/7.5 R1 
TE8) was mixed with1/10 volume of T4 ligase buffer and 4-6 gg of 
cosmid pOJ446 that had been digested with BamHI and HpaI. 65
 
After adding  0.5 p.1 (2.5 units) of T4 ligase to the ligation mixture, 
it was incubated overnight at 16 °C. 
Packaging cosmid  libraries. A 4 p.1 aliquot from the 10 p.1 
ligation mixture was used for packaging with Gigapack II XL 
Packaging Extract (Stratagene).  The manufacturer's protocol was 
followed exactly. 
Colony blotting.  2000-3000 E. coli colonies of the 
S.murayamaensis cosmid library in LB broth were spread by 
pipetting on a dried large nylon membrane(Amersham Co., 138 
mm diameter) on several dried filter papers as described by the 
manufacturer.  After spreading the inoculum, the membrane was 
transferred onto LB-agar plate containing 100 p.g /ml of apramycin 
and incubated at 37 0C overnight.  After colonies were grown well, 
the membrane was replicated onto several other membranes by 
pressing down the original membrane to new membranes on a 
sterile glass plate with another glass plate.  The orientation of 
original and replica membranes were marked with holes in the 
pair of filters with an 18-gauge needle.  The replica membranes 
were grown again on LB-apramycin plates overnight.  One of the 
replica membranes was placed colonies side up on a pad of 
Whatman 3MM absorbent filter paper soaked in denaturing 
solution (  1.5 M NaC1/ 0.5 M NaOH ) for 7 minutes.  The membrane 
was then transferred colonies side up on a pad of Whatman 3MM 
absorbent filter paper soaked in neutralizing solution (1.5 M NaC1, 
0.5 M Tris-HC1, pH 7.2, 0.001 M EDTA) for 3 minutes.  After 66 
repeating this step once more, the membranes were rinsed briefly 
in 2 x SSC, dried in air, and the DNA was then fixed in an oven at 
80 0C for 2 hours. 
Colony  hybridization.  The fixed membrane was 
prehybridized with 30 ml of prehybridization solution (5 x SSPE/5 
x Denhardt's solution/0.5% SDS/20 µg per ml of denatured salmon 
sperm DNA) in a 150 mm glass crystallizing dish at 65 0C without 
shaking.  After one hour, 105 dpm of denatured probe was added 
into the prehybridization solution and the hybridization was 
carried out at 65 0C overnight without shaking.  After 
hybridization, the filters were washed 1) two times in 2 x 
SSPE/0.1% SDS at room temperature for 10 minutes, and 2) one 
time in 1 x SSPE/0.1% SDS at 65 0C for 15 minutes, followed by 
autoradiography. 
Isolation of positive clones.  After  identification  of the 
positive clones, they were picked from the original membrane and 
inoculated onto LB-apramycin (100 µg /ml) agar plates to isolate 
single colonies.  After overnight incubation of the plate at 37 0C, 
the individual single colonies were inoculated into 2 ml of LB 
containing 50 tg /m1 of apramycin and incubated at 37 0C, 280 rpm 
overnight.  Twenty microliters of the overnight cultures were 
spotted onto a dried Amersham nylon membrane.  The DNA of the 
dot-blotted E. coli cultures were fixed and hybridized as previously 
described in colony blotting and hybridization. 67 
Southern  hybridization  of  the  recombinant  cosmids, 
transformation  of  S.lividans, and expression  test of the 
transformed S.lividans.  These procedures were discussed  in 
the Materials and Methods Section of Chapter II. 
Other Molecular  biological  techniques.  Plasmid DNA 
isolations from E. co/i and preparation of E. co/i competent cells 
were performed according to standard procedures.1 4  Restriction 
enzymes, DNA ligase and calf intestinal alkaline phosphatase (CIP) 
were purchased from Gibco BRL, New England Biolabs, United 
States Biochemical (USB), Promega and Boehringer Mannheim Co. 
and used according to the manufacturers' instruction. 68
 
Results  and Discussion
 
Southern hybridization  of  S.  murayamaensis genomic DNA
with act/- OR Fl 
The genomic DNA isolation from Streptomyces is problematic 
due to thick cell wall and strong endonuclease activity.  The 
method discussed in the Streptomyces Lab Manuall 5 worked fine 
only for some Streptomyces species such as S.  lividans or S. 
coelicolor.  This method extracts genomic DNA from broken cells 
which were prepared by treatment with lysozyme treatment 
followed by SDS treatment.  However, many Streptomyces, such as 
S.  murayamaensis, require a long incubation step (up to 1 hour) 
with lysozyme at 30-37 0C, this method always ends up with 
significant genomic DNA degradation by endogenous endonuclease 
activity during this long incubation.  During this research, a very 
simple and efficient genomic DNA isolation method for 
Streptomyces was developed.  In this method, Streptomyces 
mycelia were briefly treated with lysozyme and achromopeptidase 
to weaken the cell wall.  Completely digested cells were then 
prepared by treatment with proteinase K overnight at 50 °C.  At 
this temperature, the DNase activity is almost completely inhibited 
while the proteinase K eventually destroys these proteins.  This 
method gave very good quality genomic DNA for every 
Streptomyces strain so far tested in our laboratory. 
The DNA sequence of ketosynthase genes such as actl -ORF1 is 
strongly conserved among the Type II PKS genes without exception 69
 
(Figure I-4).6,7  So, in this work, actl -ORF1 was choosen as a probe 
to identify aromatic PKS gene clusters of S.  murayamaensis. 
The actl -ORF1 DNA fragment was labeled with a 32P random 
labeling kit and hybridized at moderate stringency (2 x SSC/1% 
SDS) against Southern blots of digested chromosomal DNA from S. 
murayamaensis (Figure 111-2).  The BamHI digested genomic DNA 
gave signals for fragments of ca. 5.6 kbp, 4.3 kbp, 2.6 kbp and 0.5 
kbp.  The four bands were expected from Southern hybridization 
results with the lambda clones discussed in Chapter II.  The 5.6 
kbp BamHI fragment is exactly equivalent to the 5.6 kbp BamHI 
fragment of clone 10a (Figure 11-6).  The remaining three matched 
the actl homologous bands of 4.3 kbp, 2.6 kbp and 0.5 kbp of 
lambda clone 6A1.  The Southern hybridization against KpnI and 
Pstl digested genomic DNA showed only two bands each.  All of 
this strongly suggested that there were only two actl homologous 
PKS gene clusters in S.  murayamaensis. 
Isolation of actl homologous clones from an S . 
m urayamaensis  cosmid  library 
Cosmid pOJ446 was constructed with dual replication origins for 
propagation in either Streptomyces sp. (Scp2*) or E. coli (pUC), and 
the amR gene confers resistance to apramycin upon both bacteria. 
It also contains OriT, a region of DNA that permits conjugal transfer 
from E. coli to Streptomyces sp. E. coli XL1-Blue MR, used as a 
cloning host, is a homologous recombination deficient (recA-) strain 
so that recombinant cosmids can propagate stably in the E. coli 
without losing their insert by an intramolecular or intermolecular 70 
1  2 3 
23.1  kb-­
9.4 kb 
23.1  kb 6.7 kb-­
-9.4 kb 
4.4 kb-- --6.7 kb 
4.4 kb 
2.3 kb-- 2.3  kb 
2.0 kb-- -22.0 kb 
Figure  111-2.  Southern  hybridization  of  digested 
Streptomyces  murayamaensis chromosomal DNA (A) and 
the  two corresponding  cloned PKS gene  clusters  prepared 
by BamHI digestion (B).  A) Lane 1, BamHI digestion; lane 2, 
KpnI digestion; lane 3, PstI digestion. 71
 
recombination process.  A cosmid library containing S. 
murayamaensis genomic DNA fragments of ca. 40 kbp from partial 
MboI digestion was constructed using the pOJ446 in the E. coli 
XL1-Blue MR. 
Since the lambda PKS gene clones (Chapter II) originally 
suggested the presence of several PKS gene clusters, about 6000 
individual E. coli colonies were thoroughly screened with the actI­
ORF1 probe.  This led to the identification of 38 positive clones. 
Based on restriction digestion followed by Southern hybridization, 
it was found that the 38 clones could be grouped into just two 
clusters.  Of these, 23 clones were grouped into Cluster I, and 15 
clones were grouped into the Cluster II.  The DNA of Cluster I 
contains the 5.6 kbp BamHI DNA fragment that hybridized with 
actl -ORF1 (Figure 111-2).  The Cluster II DNA contains the three 
BamHI DNA fragments that hybridized with actl -ORF1 (Figure III­
2).  Figure 111-2 (B) shows Southern hybridization with BamHI 
digested DNA from one cosmid clone from each of the two clusters. 
This clearly demonstrated that the two PKS gene clusters of S. 
murayamaensis were successfully cloned. 
Cloning S.  murayamaensis PKS gene clusters through a cosmid 
library potentially has a number of advantages over cloning 
through a bacteriophage library(Chapter II).  The large DNA 
fragments (30-45 kb) can increase the chance of expressing a 
recognizable product from the cloned PKS genes.  Also, the larger 
cosmid inserts of the genomic DNA made it easier to correctly 
group PKS clones.  Due to the relatively small size of the lambda 
inserts,  it was more likely that the 15-20 kbp fragments would not 72 
include the full set of genes being probed.  The only lambda clones 
6A1, 10a, 13a, 14a, and 17a seems to have real PKS gene inserts. 
The restriction map of other lambda clones did not match with 
either Cluster I or Cluster II obtained from the cosmid clones. The 
weak Southern hybridization signals from these lambda clones 
may have come from non-specific binding of the probe to genes 
which are slightly homologous to PKS genes, such as those for fatty 
acid biosynthesis. 
Heterologous  expression  of  a  putative  kinamycin 
biosynthetic  gene 
Ten cosmid clones from Cluster I and 8 clones from Cluster II 
were introduced into S.  lividans by transformation to identify the 
product of the PKS genes by heterologous expression (Table III-1). 
The transformation efficiency of S.  lividans with either cluster was 
about 100 times lower than the transformation efficiency of S. 
lividans  with the cosmid itself.  Also, transformants showed the 
typical phenotype of S.  lividans growing in a stress condition. 
Based on the lower transformation efficiency and the stress 
phenotype, it was considered that both types of recombinant 
plasmids led to heterologous  expression of secondary metabolites 
which may be potentially harmful to the host strain.  S.  lividans 
transformants with two of the clones (pSH1500 and pSH1580) of 
Cluster II produced a green pigment in R2YE and grew especially 
slowly. Table  III-1.  Bacterial  strains  and  plasmids  used  in  this  study 
Strains  or  plasmids  Relevant  characteristics	  Source  or 
reference 
Bacterial  strains 
S.  muravamaensis	  Murayaqui none  and  Kinamyci ns  prod ucer  2 
E. coli	  XL1-BlueMR  A(mcrA)183,  d(rncrCB-lisdSMR-mrril 73,  endAl,  supE44.  thi-1,  Stratagene 
recAl,  gryA96,relA I,  lac 
S.  lividans TK 24	  Host for expression test (SLP2-, SLP3- John  Innes 
Institute 
Plasmids 
p0J446  E.coli-Streptomyces Shuttle cosinid  5 
pSH1500  Cluster  II +pOJ446, produce PK I  and PK2 in  S.  lividans  This work 
pSH1510  Cluster  II +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1520  Cluster  II +pOJ446, did not produce  any new metabolite in S.  lividans  This work 
pSH1530  Cluster  II +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1540  Cluster  II +pOJ446, did not produce  any new metabolite in S.  lividans  This work 
pSH1550  Cluster  11+p0J446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1560  Cluster  II +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pS H1570  Cluster  II +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1580  Cluster  II +pOJ446, produce PK 1  and  PK2 in  S.  lividans  This work 
pSH1000  Cluster  I +pOJ446, did not produce  any new metabolite in S.  lividans  This work 
pSH1010  Cluster  l+p0J446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1020  Cluster  l+p0J446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1030  Cluster  I +pOJ446, did not produce  any new metabolite  in  S.  lividans  This work 
pSH1040  Cluster  1+p01446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1050  Cluster  I +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1060  Cluster  I +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1070  Cluster  l+p0J446, did not produce  any new metabolite in  S.  lividans  This work 
pSH1080  Cluster  I +pOJ446, did not produce  any new metabolite  in  S.  lividans  This work 
pSH1090  Cluster  I +pOJ446, did not produce  any new metabolite in  S.  lividans  This work 74 
It has been well known that Streptomyces  lividans TK24 
sometimes eliminates foreign DNA inserts by intramolecular 
recombination.22,23  Because of this possibility, multiple colonies 
were inoculated into liquid media instead of single colonies.  After 
growing the transformants on R2YE agar for 7-10 days,  multiple 
colonies were scraped off from the plates to inoculate 5 ml of YEME 
media.  A large quantity of cells was used for inoculation to reduce 
the chance of intramolecular recombination, since fewer cell 
divisions would be required to reach log-phase.  If we assume the 
probability of losing the insert is 0.1 % at each cell division, it is 
obvious that fewer cell divisions are much better for the 
expression test.  After growing the seed culture for 3-4 days, 
depending on growth of the transformants,  0.3 ml of the seed 
culture was used to inoculate 5 ml each of GPS and YEME for 
production, and these were incubated for 7 days.  The cultures 
were extracted with ethyl acetate.  The extracts were analyzed 
using photodiode array HPLC. 
The HPLC analysis showed that the Cluster I transformants did 
not produce any new metabolites in S.  lividans.  The cosmids were 
re-isolated from these S.  lividans strains to see whether they still 
had an intact insert.  Restriction analysis of the cosmid DNA 
showed that all of clones had lost more than half of their insert, 
presumably by an intramolecular recombination process.  As 
shown in Figure 11-3, the right end of the cluster I PKS gene has an 
unusually large number of Sall sites, indicating that the region 
may be a repetitive area.  Repetitive areas very easily lose insert 
by intramolecular recombination.14  The instability of this PKS 75 
gene cluster may explain why there was no expression of the PKS 
genes in S.  lividans TK24. A different host, such as S.  lividans 
JT4622 or ZX724 having  no intramolecular recombination activity, 
will be needed for an expression test of this cluster. 
Two clones (pSH1500 and pSH1580) of Cluster II produced two 
new metabolites (PK1, putative kinamycin  and PK2, putative 1 
kinamycin 2) in S.  lividans.  Figure 111-3 shows the HPLC traces of 
S.  lividans with just the vector, pOJ446, and with the recombinant 
cosmid, pSH1580.  The UV-visible absorption spectra, obtained by 
photodiode array detection, are shown in Figure 111-4.  PK1 started 
to be detected at an early stage of the fermentation (starting from 
2 days in GPS), while PK2 was produced in the late stage of 
fermentation (usually after 5 days in GPS).  In YEME, only PK1 was 
produced after 5 days of growth.  The UV-visible spectrum and 
retention time of PK1 (Figure 111-4) exactly matched one of 
metabolites previously observed to be produced by S. 
murayamaensis MC1,  a kinamycin-deficient mutant generated by 
NTG treatment.25 A large fermentation of S. lividansIpSH1580 
(1L, GPS) was carried out and compound PK1 was isolated and 
purified.  The chemical structure of this compound has been 
examined by 1H NM, 13C NM and high resolution mass 
spectrometry.  It appears to be either 3a or 3b, and this work is 
continuing.2 6 76 
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While elucidation of the structure of PK1 is not yet complete, this 
compound is clearly related to kinamycin intermediates.  It was 
also observed in the kinamycin-negative mutant strain MC1, which 
produces kinafluorenone, (4),  a shunt metabolite derived from the 
kinamycin biosynthetic intermediate kinobscurinone (5).  Thus, 
PK1 appears to also be a shunt product from this pathway. 77
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Chapter  IV
 
Cloning and complete heterologous  expression  of 
the  tetrangulol  biosynthetic  gene  cluster  from 
Streptomyces  rimosus and the  PD 116740 
biosynthetic gene cluster from Streptomyces WP 
4669 
Introduction 
Angucyclines, a name recently given to naturally occurring 
benz[a]anthraquinones, are a rapidly growing group of polyketide 
natural products, involving many bioactive compounds .2 1 
Tetrangulol and tetrangomycin, isolated from Streptomyces 
rimosus, were the first identified members of this class of 
antibiotics .22  Streptomyces WP  4669 produces an angucycline, 
PD 116740, which has activity against L1210 lymphocytic 
leukemia and HCT-8 colon adenocarcinoma cell lines.1 
Dehydrorabelomycin, the 6-hydroxy analog of tetrangulol, has 
been isolated from Streptomyces  murayamaensis and is an 
intermediate in the biosynthesis of the kinamycin antibiotics 
(Figure II-1).2 3 
All of the three compounds, dehydrorabelomycin, PD  116740, 
and tetrangulol, are derived biosynthetically from the predictable 
folding of a decaketide precursor.2,23  The hydroxyl oxygen at  C-6 
of dehydrorabelomycin was shown to be derived from the original 84 
acetate precursor, while the corresponding oxygen in the 
PD116740 was shown to be derived from water.2  Biosynthetic 
research in our group during recent years has shown that 
tetrangulol is the key intermediate in the biosynthesis of PD 
116740 in S. WP 4669.17  In addition, the data clearly indicated 
that its 6-hydroxy analog, dehydrorabelomycin, was not  an 
intermediate.  These results indicated that deoxygenation at C-6 to 
yield tetrangulol is a prearomatic process.  Conversion of 
tetrangulol to PD 116740 in S. WP 4669 required a minimum of 
four steps in an undefined order: 0-methylation, arylmethyl­
oxygenation, and a sequence of epoxidation and hydrolysis to 
generate the trans-diol in the K-region of the angular structure 
(Figure IV-1). 
Molecular genetic studies have provided the detailed functions 
of individual enzymes of aromatic PKS, particularly those 
governing the early steps of polyketide biosynthesis.  This work 
became possible by expressing cassettes of individual genes of 
aromatic PKS on a suitable vector into S.  coelicolor which was 
devoid of the normal type II PKS.11  Linear cyclic polyketides and 
angular cyclic polyketides (angucyclines) are formed by unknown 
mechanisms folding polyketide backbones produced from the 
minimal PKSs.  We were interested in which factor(s) direct 
polyketide folding to produce the angular ring systems, as well as 
in the enzymology of unusual oxygenations, such as those occurring 
in the biosynthetic steps from tetrangulol to PD 116740.  This 
curiosity led us to investigate the genetics of the tetrangulol and 
PD 116740 pathways.  We describe here the cloning of the whole 85 
tetrangulol biosynthetic gene cluster from S.  rimosus and the 
whole PD 116740 biosynthetic gene cluster from S. WP 4669, as 
demonstrated by complete expression of these pathways in a 
heterologous host. 10 x CH3COSCoA 
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Figure  IV-1.  proposed  biosynthetic  pathway  for PD  116740
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Materials  and Methods
 
All  of  the  experimental  procedures  were  basically  same 
as  in  the Materials and Methods section of Chapter  II  or 
Chapter  III  except  the  following: 
Culture condition  for  S.  rimosus or Streptomyces WP 
4669.  S.  rimosus or S. WP 4669 were propagated on ISPII agar 
medium32 in a 27 0C incubator for spore preparation or in YEME 
liquid media at 27 0C for genomic DNA preparation. 
S.  rimosus and S. WP 4669 genomic DNA isolation.  The 
genomic DNA preparations for these two strains were basically 
same as discussed in Chapter III except that the achromopeptidase 
was not necessary to destroy the cell walls. 
Isolation of 30-40 kb DNA fragments of S. WP 4669 
genomic DNA. The MboI partial digested genomic DNA (300 [tg) 
was loaded onto a 0.3 % gel of low-melting agarose (USB Co.).  After 
overnight electrophoresis in TAE buffer, the 30-40 kb fragments 
were cut out from the gel, and the agarose slices were dissolved by 
incubation for 10 minutes at 70 °C.  After extraction of agarose 
with phenol (pH 8.0), phenol/CHC13 (pH 8.0), and CHC13, the DNA 
was concentrated by ethanol precipitation.  The typical yield of the 
isolated DNA was 2-4 [ig in 9 p,1 TE. 88 
Ligation of genomic DNA to cosmid pOJ446.  7 41 of the 
isolated 30-40 kb insert (2-3 4g) was mixed with 1.5  .t.1 of BamHI 
and Hpal digested pOJ446 (4-6 4g) in a 9.5 ill  ligation mixture. 
After adding  0.5 41 (2.5 unit) of T4 ligase to the ligation mixture, it 
was incubated for overnight at 16 °C. 89
 
Results
 
I.	  Cloning and Complete Heterologous Expression  of 
Tetrangulol Biosynthetic Gene Cluster from S.  rimosus 
Detection of actl homologous DNA regions from the S . 
rimosus genome 
S. rimosus genomic DNA was prepared using the proteinase K 
method described in Chapter III.  The actl -ORF1 DNA fragment, 
coding for the ketosynthase gene, is highly conserved among all of 
known aromatic PKS genes.4,5  The genomic DNA of S. rimosus was 
digested with BamHI, Kpnl, Pstl and Sall.  The digested DNAs were 
separated by electrophoresis and probed with 32P-radiolabeled 
actl -ORF1 at moderate stringency (2 x SSC/1% SDS, Figure IV-2, A). 
The probe hybridized with two BamHI DNA fragments (13.7 kb 
and 11.2 kb).  The Southern hybridization results from the KpnI 
and Sall genomic DNA digests showed that two DNA bands were 
also homologous to actI in each case.  This suggested that there 
were two PKS gene clusters in S.  rimosus. Pstl digestion yielded a 
single large band (30 > kb), indicating that PstI sites are very rare 
in both PKS gene clusters. 
The presence of two PKS gene clusters in S. rimosus is not 
surprising.  Many Streptomyces sp. have more than one PKS gene 
cluster.  For example, S.  murayamaensis contains the two PKS gene 
clusters (Chapter III) for kinamycins and an unidentified PKS, S. 
WP 4669 has two PKS gene clusters for PD 116740 and an 90
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digestion; lane 4, Sall digestion. 91
 
unidentified PKS, and S.  coelicolor has PKS gene clusters for 
actinorhodin22 and for  a spore pigment.2 3 
Isolation of the two PKS gene clusters from S.  rimosus 
A cosmid library containing genomic DNA fragments of 30-43 kb 
was constructed from Streptomyces  rimosus as described in the 
Materials and Methods section.  About 2,500 colonies from the 
Streptomyces  rimosus cosmid library were screened with the actl­
ORF1 probe.  Screening of the library with the probe led to the 
identification of 39 hybridizing clones.  Each of the 39 recombinant 
cosmids was digested with BamHI and EcoRI, and then hybridized 
with actl -ORF1.  Restriction mapping and Southern hybridization 
results clearly showed that the 39 clones could be divided into two 
nonoverlapping sets, 15 clones for one PKS gene cluster (Cluster I) 
and 24 clones for the other cluster (Cluster II).  As shown in Figure 
IV-2, B, the first PKS gene cluster, comprising 24 clones, contains 
one actl homologous BamHI fragment (13.7 kb).  The DNA from 
second cluster contains an 11.2 kb actl homologous BamHI 
fragment.  The two actl homologous BamHI fragments (Figure IV­
2, B) were exactly equivalent to the two actl homologous BamHI 
bands observed in Southern hybridization analysis of S.  rimosus 
genomic DNA (Figure IV-2, A).  This provides strong evidence that 
the two PKS gene clusters detected initially by the Southern 
hybridization of S. rimosus genomic DNA were successfully cloned 
without rearrangement or deletion. 92 
Expression test of the two PKS gene clusters  in  S.  lividans 
Eight recombinant cosmids from Cluster I and 10 from Cluster II 
were introduced by transformation into S.  lividans TK24. The S. 
lividans transformants showed about 100 times lower 
transformation efficiency than  S.  lividans transformed with the 
cosmid itself.  Also, transformants showed the typical phenotype of 
S. lividans growing under stress conditions.  The observed lowering 
of transformation efficiency and change in phenotype might 
indicate that both clusters express a gene product which is harmful 
to the host strain.  In Streptomyces, gene products harmful to the 
host strain are most likely to be secondary metabolites. 
After 7 days, multiple colonies from each transformant were 
scraped from the R2YE agar plates and used to inoculate 5 ml of 
YEME medium.  After growing the seed culture for 3-4 days 
(depending on growth of the transformants),  a portion of the seed 
culture (0.3 ml) was used to inoculate GPS13 and Glycerol-
Asparagine (Gly-Asn)15 media, respectively, for secondary 
metabolite production.  The cultures were then incubated for 5 
more days. 
The cultures were extracted with ethyl acetate, then analyzed 
using photodiode array HPLC.  This analysis provided evidence that 
PKS gene Cluster I produces tetrangulol and two unidentified 
compounds one of which might be tetrangomycin (Table IV-1). 
Thus, chromatography on a reverse-phase HPLC column (Figure 
IV-3) identified a compound matching the retention time Table  IV-1.  Bacterial  strains  and  plasmids  used  in  this  study 
Strains  or  plasmids  Relevant  characteristics	  Source  or 
reference 
Bacterial  strains 
S.  rimosus	  tetrangulol  producer  14 
E. coli	  XL I -BlueMR  ,A(mcrA)I83,  A(mcrCB-hsdSMR-mrr)173,  endAl,  supE44,  Strata gene 
recAl,  gryA96,relAI,  lac 
S. lividans TK 24	  Host for expression test (SLI32-, SI.133-)  John  Innes 
Institute 
Plasm ids 
pOJ446  E.coli-Streptomyces Shuttle cosmid 20 
pSH2010  1 +p0J446, produces tetrangulol, PTI, and PHI in S.lividans  This work 
pS H2020  1 +p0J446, produces tetrangulol, PT I ,  and PHI in S.lividans 
pSH2030  l+p0J446, produces tetrangulol, PTI, and PHI in S.lividans This  work 
pS H2040  l+p0J446, produces tetrangulol, PT1, and PHI in S.lividans  This  work 
pS H2050  I +p0J446, does not produces tetrangulol, PT1, and PHI in S.lividans  This  work 
pSH2060  1 +p0J446, does not produces tetrangulol, PTI, and PHI in S.lividans  This  work 
pSH2070  1 +p0J446, produces tetrangulol, PT], and PHI in S.lividans This  work 
pSH2080  1 +p0J446, produces tetrangulol, PT1, and PHI in S.lividans  This  work 
pS H2510  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2520  Unidentified  polyketide  biosynthetic  gene cluster+p0J446  This  work 
pSH2530  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2540  Unidentified  polyketide  biosynthetic  gene  cluster+p0J446  This  work 
pSH2550  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2560  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2570  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2580  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
pSH2590  Unidentified  polyketide  biosynthetic  gene  cluster+p0J446  This  work 
pSH2600  Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446  This  work 
1;  tetrangulol biosynthetic gene cluster
 S. lividans I p0J446 
A254 
S. lividans I pSH2020 
H1  PT1 
,Tet 
J`t 
10  20  30 
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Figure  IV-3. HPLC trace  of S.  lividans  transformant pSH2020 compared  to  S . 
lividans/p0J446 and S.  rimosus.  The peaks of tetrangulol (Tet), PH1, and PT1 are indicated
by arrows. 95
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Figure  IV-4.  Spectrum  index  plot  of  tetrangulol  produced 
by  S.  lividans  transformant pSH2020.  Tetrangulol  sample 
was prepared by unambiguous synthesis. 96 
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and displaying the same UV-Visible spectrum as tetrangulol 
(Figure IV-4).  In order to confirm the assignment, tetrangulol was 
isolated from a 500 ml fermentation (clone pSH2020) and its 
structure was confirmed by 1H NM spectroscopy.24 
Two new compounds were identifiable from the tetrangulol­
producing S.  lividans transformants (Figure IV-3 and IV-5).  One 
compound PT1 (PT=putative tetrangomycin) with a retention time 
of 22.6 min was produced both by wild-type S.  rimosus and by 
tetrangulol-producing  S.  lividans transformants.  PT1 is most likely 
tetrangomycin because S. rimosus is known to produce both 
tetrangulol and tetrangomycin.  S.  lividans transformants 
producing tetrangulol produced another new major metabolite PH1 
(PH=putative hybrid), retention time at 16.1 min in HPLC profile. 
PH1 was not observed in extracts of either S.  rimosus or S.  lividans. 
Although the complete structure has not yet been determined, 1H 
NM and 13 C-NM spectra of the compound clearly indicate that it is 
an  angucycline.24  Since there is no evidence that S.  lividans, the 
most well-studied Streptomyces species, contains an angucycline 
pathway, the presence of PH1 suggests that its formation involves 
genes derived from the tetrangulol biosynthetic pathway.  Thus, 
this compound may be a hybrid metabolite between the 
tetrangulol biosynthetic pathway and S.  lividans metabolism. 
HPLC analysis of extracts of cultures of S.  lividans transformants 
with Cluster II showed that the cluster did not express any 
identifiable S.  rimosus metabolites in S.  lividans.  The altered 
colony morphology of the S.  lividans transformants and the 
transformation efficiency with Cluster II suggests that this DNA 98 
also codes for production of polyketide compound in S.  lividans 
that cause stress to the host.  However, the pathway seems like 
unstable in the S.  lividans host.  The tiny amount of polyketide 
production from the unstable pathway seemed like giving enough 
stress to the S.  lividans host but not enough to be detected by the 
HPLC analysis. 
Tetrangulol  biosynthetic  gene  cluster 
A restriction map of the tetrangulol biosynthetic PKS gene 
cluster is shown in Figure V-6.  S.  lividansIpSH2020 and S. 
/ividans/pSH2030 produce the same quantity of tetrangulol as wild 
type S.  rimosus.  The overlapping inserts in pSH2020 and pSH2030 
represent about 30 kb of contiguous DNA from Streptomyces 
rimosus, and this region is apparently sufficient to encode the 
entire  tetrangulol biosynthetic pathway. 99
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pSH2030 
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if16.8 kb  1.8 kb  24.2 kb 
Entire tetrangulol biosynthetic gene 
cluster contained in this region 
Figure  IV-6.  Restriction map of the  entire  tetrangulol
biosynthetic gene cluster from S.  rimosus.  The black boxes 
represent the fragment to which act/-ORF1  hybridized. 
Abbreviation of restriction enzymes:  EI; EcoRI. EV; EcoRV. 100
 
II.	  Cloning and Complete Heterologous  Expression  of 
PD 116740 Biosynthetic Gene Cluster from S. WP 4669 
Detection of actl homologous DNA regions in  S. WP 4669 
S. WP 4669 genomic DNA was prepared by using proteinase K as 
descried in Chapter III.  Portions of genomic DNA from S. WP 4669 
was digested with BamHI, KpnI, PstI and Sall.  The digested DNA 
fragments were separated by electrophoresis and hybridized with 
actl -ORF1 at moderate stringency (2 x SSC/1% SDS, Figure IV-7, A). 
The probe hybridized with three BamHI digested DNA fragments 
(16.9 kb, 12.1 kb and 6.9 kb).  The southern hybridization results 
for genomic DNA digested by Kpnl, PstI and by Sall showed that 
two DNA fragments are homologous to actl in each case.  This 
clearly suggested the presence of two PKS gene clusters in which 
one cluster has one internal Barn HI site in the act! 0 R F 1 
homologous region. 
Isolation of the two PKS gene clusters from S. WP 4669 
A cosmid library containing genomic DNA fragments of 30-43 kb 
was constructed from S. WP 4669 as described in the Materials and 
Methods section.  About 2500 colonies from the S. WP 4669 
cosmid library were screened with the actl -ORF1 probe.  On 
screening of the library with the probe, 12 hybridizing clones were 
identified.  The 12 recombinant cosmids were each digested with 101
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Figure  IV-7.  Southern hybridization  of  digested  S. WP 
4669 chromosomal DNA (A) and  the  two corresponding
cloned PKS gene clusters prepared by Barn HI  digestion 
(B). A) Lane 1, BamHI digestion; lane 2, Kpnl digestion; lane 3, Pst1 
digestion; lane 4, Sall digestion. 102
 
BamHI and EcoRI, and then hybridized with actl -ORF1.  The 
restriction mapping and Southern hybridization results clearly 
showed that the 12 clones divided into two nonoverlapping sets, 5 
clones for one PKS gene cluster and 7 clones for the other cluster. 
As shown in Figure IV-7, B, the first PKS gene cluster (Cluster I) 
comprising 5 clones contains characteristically two actl homologous 
BamHI fragments (12.1 kb and 6.9 kb).  The DNA from the second 
cluster (Cluster II) contained a 16.9 kb actl homologous BamHI 
fragment.  These three actl homologous BarnHI fragments were 
exactly equivalent to the ones observed in Southern hybridization 
analysis of S. WP 4669 genomic DNA. This means the two PKS gene 
clusters shown by the Southern hybridization of S. WP 4669 were 
successfully cloned. 
Expression test of the two PKS gene clusters  in  S.  lividans 
All of the 12 isolated cosmids containing two PKS gene clusters 
were introduced by transformation into S.  lividans TK24, as 
described in the previous sections.  Multiple colonies of S.  lividans 
transformants were scraped from each plate for expression tests. 
The expression tests were conducted in three different media: 
GPS,13 YEME14 and Glycerol-Asparagine (Gly-Asn).15 
The S.  lividans transformants from Cluster I showed normal 
transformation efficiency.  The transformant colonies grow very 
easily and were well-sporulated.  HPLC analysis of the 
transformant culture in GPS, YEME, and Gly-Asn media showed 
that no new identifiable compounds were produced from these 103 
cultures. Based on the colony morphology, transformation 
efficiency, and HPLC analysis, the PKS gene cluster might code for 
just a null-PKS compound or a compound specifically expressed at 
very late stage of life cycle of the organism, like thewhi gene in S. 
coelicolor, which is expressed to help sporulation.16  This idea is 
supported by the fact that S. WP 4669 is extremely well sporulated 
in any media. 
S.  lividans  transformants from Cluster II showed about 100 
times lower transformation efficiency compared to the vector 
itself.  One cosmid clone (pSH3030) was never able to transform S. 
lividans.  The transformant colonies grew extremely slowly.  Also, 
the transformants generally  sporulated very poorly and produced 
extremely poor pigment in R2YE agar.  The lower transformation 
efficiency of the recombinant cosmids containing Cluster II might 
come from a gene dosage effect that over-expression of the foreign 
secondary metabolites kill the host strain. 
HPLC analysis of the cultures grown in GPS medium from the 
transformants from Cluster II showed that 3 out of the 6 clones 
tested were able to yield heterologous expression of the PD 116740 
pathway in S.  lividans  (Table IV-2).  In YEME medium, only 
intermediate compounds of the PD 116740 biosynthetic pathway 
were observed.  In Gly-Asn medium, no PD 116740 or its 
intermediates were produced from both S. WP 4669 wild type 
strain and the transformants.  PD 116740 is produced from S. WP 
4669 only in the early stationary phase in nutrient rich media and 
it  disappears Table 
Strains  or plasmids 
Bacterial  strains 
Streptomyces WP4669 
E. coli  XL1- BIueMR 
S. lividans TK 24 
Plasmids 
p01446 
pSH3010 
pS H3020
 
pSH3030
 
pSH3040
 
pSH3050
 
pSH3060
 
pSH3071
 
pSH3510
 
pSH3520
 
pSH3530
 
pSH3540
 
pSH3550
 
IV-2.  Bacterial  strains  and  plasmids  used  in 
Relevant  characteristics 
PD 116740 producer
 
4(mcrA)183,  4(merCB-hsdSMR-Inrr)173,  endAl,  supE44,
 
thi-1,  recAl,  gryA96,re1A1, be
 
Host for expression  test (SLP2-,
 
E.coli-Streptomyces Shuttle cosmic' 
PD 116740 biosynthetic gene cluster+p0J446, produces PD
116740 and intermediate compounds in S.lividans 
PD 116740 biosynthetic gene cluster +pOJ446, does not
produce PD 116740 or intermediate compounds in  S.  lividans 
PD 116740 biosynthetic gene cluster +pOJ446,  can not 
transform  S.  lividans 
PD 116740 biosynthetic gene cluster +pOJ446, does not
produce PD 116740 or intermediate compounds in  S.  lividans 
PD 116740 biosynthetic gene cluster +pOJ446, does not
produce PD 116740 or intermediate compounds in  S.  lividans 
PD 116740 biosynthetic gene cluster +pOJ446, produces PD
116740 and intermediate compounds in  S.  lividans 
PD 116740 biosynthetic gene cluster +pOJ446, produces PD
116740 and intermediate compounds in  S.  lividans 
Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446
Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446
Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446
Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446
Unidentified  polyketide  biosynthetic  gene  cluster +pOJ446 
this  study 
Source  or 
reference 
1 
Stratagene 
John  I n nes 
Institute 
20 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 
This work 105 
rapidly after passing through this phase.  The pathway was never 
expressed in minimal media by the original organism.  Thus, the 
lack of production of PD 116740 in Gly-Asn in S.  lividans is 
consistent with the early metabolic characteristic of PD 116740. 
This means the PD 116740 biosynthetic pathway in a heterologous 
host, i.e. S.  lividans, may be regulated exactly same as in its 
original host. 
The formation of PD 116740 by the S.  lividans transformants 
was confirmed using reversed-phase HPLC (Figure IV-8), equipped 
with a photodiode array detector (Figures IV-9).  Also, PD 116740 
was isolated from 500 ml fermentations (clones pSH3071 and 
pSH3060) and its structure was confirmed by 1H NM 
spectrosc opy.24 
The HPLC analysis showed that the PD 116740 pathway in S. 
lividans  accumulated more intermediate compounds than PD 
116740.  Wild type S. WP 4669 produces much larger quantities of 
PD 116740 than intermediate compounds, and  one compound, 19­
hydroxy-8-0-methyl-tetrangulol (HMT, Figure IV-1) was almost 
unidentifiable in extracts from S. WP 4669 while the compound 
was very easily recognizable in extracts from the S. lividans 
transformants. We can explain the phenomenon in two different 
ways.  First, the last modifying enzyme leading to PD 116740 may 
not be well-expressed in the heterologous host.  Alternatively,  the S. lividans I pOJ446 
A254 
Streptomyces sp. WP4669 
S. lividans I pSH3071 
uu 
10 
Time, minutes 
20  30 
Figure IV-8. HPLC trace  of  S.  lividans  transformant pSH3071 compared  to  S. 
lividans /pOJ446 and Streptomyces WP 4669.  The PD 116740 peaks are indicated by 
arrows.  o
ch 8.77 min 
A 
14.79 min  24.4 min 
PD116740  HMT  Tetrangulol
0.30 
o. 
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0.00 
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Figure  1V-9.  Spectrum  index  plot  of PD  116740  and  intermediate  compounds 
produced by  S.  lividans  transformant  pSH3071. UV-Visible spectra  of the compounds of 
the S.  lividans transformant were confirmed by matching the spectra and retention times with 
standard compounds.  Samples of intermediate compounds were prepared by unambiguous 
synthesis. 108
 
modifying enzyme may be less active under the different 
physiological conditions in the heterologous host. 
PD 116740  biosynthetic  gene  cluster 
A restriction map of the PD 116740 biosynthetic PKS gene 
cluster is shown in Figure IV-10.  Since the overlapping insert in 
pSH3060 and pSH3071 represents about 30 kb of contiguous DNA 
from S. WP 4669, this is apparently enough to encode the entire PD 
116740 biosynthetic pathway.  The plasmid pSH3030 was never 
able to transform S.  lividans.  This means that the 14-17 kb area, 
right end of the pSH3060 and pSH3071 insert, may encode a kind 
of resistance gene(s) which protect the host strain from its own 
antibiotic (PD116740). 109
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Figure IV-10.  Restriction map of the  entire PD 116740 
biosynthetic  gene  cluster  from Streptontyces WP 4669.
The black boxes represent fragment to which actl  hybridized. 
Abbreviation of restriction enzymes: EI; EcoRI. EV; EcoRV 110
 
Discussion
 
The aromatic polyketide oxytetracycline (OTC) is produced by a 
different S.  rimosus strain than the one used in our studies.25 The 
PKS gene cluster for the OTC pathway was cloned by Binnie et a/.26 
Interestingly, the S.  rimosus strain used in our work is clearly 
resistant to OTC (up to 500 µg /ml), which led us to consider 
whether our strain may have the OTC pathway.  However, both of 
the restriction maps of the two PKS clusters isolated from our 
S. rimosus strain were completely different from the reported OTC 
PKS cluster (data not shown).  The OTC biosynthetic genes are 
notoriously unstable in an industrial strain of S.  rimosus.  When 
the industrial strain was propagated as spores, 80 percent of the 
spores naturally lost the OTC biosynthetic genes.27 The S.  rimosus 
strain used in our work may harbor only the OTC resistance gene 
while the biosynthetic genes have been lost. 
An unexpectedly large number of apparent positive clones were 
observed upon screening of the S.  rimosus cosmid library with the 
actl -ORF1 probe.  There are several possible reasons.  Both PKS 
gene clusters may be present as multicopy genes.  A second 
possibility is that both PKS clusters in S.  rimosus might may be 
located on a giant linear plasmid which is present as several copies. 
Several hundred kb giant linear plasmids are common in 
Streptomyces,  including S.  rimosus  which has been reported to 
have several different giant linear plasmids.28-30  The detailed 
biological functions including copy number of the plasmids are not 1 1 1
 
yet known.  The copy number of one giant linear plasmid in S. 
coelicolor was determined  to be 3.7.31  The copy number of the 
giant plasmid in S.  coelicolor suggests that copy number of the 
giant plasmid of closely related strains, such as S.  rimosus, should 
be also 3-4.  This strongly supports the idea of the plasmid-borne 
PKS gene clusters because three to four times as many positive 
clones as expected were obtained. 
PD 116740 is formed from the cyclization of a decaketide 
intermediate folded in a manner to generate the angular cyclic 
skeleton.2  The compound is biosynthetically interesting because a 
unique 5,6-dihydroxy functionality is present in its C ring.  Recent 
biosynthetic studies in this group showed that the C-6 hydroxyl 
group did not originate from acetate-derived  oxygen.17  However, 
the C-5 hydroxyl was labeled by molecular oxygen.  These results 
indicated that generation of the 5,6-trans-diol moiety  occurred by 
enzymatic epoxidation of the K-region double bond followed by 
action of an epoxide hydrolase.  These biosynthetic studies also 
showed that tetrangulol is a key intermediate in the biosynthesis 
of PD 116740 (Figure IV-1).  However, the intermediates from 
tetrangulol to PD 116740 were not clear.  Based on the chemical 
structures of PD 116740 and tetrangulol, the possible candidates 
for intermediate compounds were believed to be 8-0­
methyltetrangulol (MT),  19-hydroxy-tetrangulol (HT),  19-hydroxy­
8-0-methyltetrangulol (HMT) or dihydro-5,6-dihydroxytetrangulol 
(DT).  One of the proposed intermediates, HMT, was isolated by 
Brinkman et al. from the wild-type S. WP 4669.18  However, the 1 1 2
 
rest of the putative intermediates were only considered as 
potential precursors to PD 116740. 
The S.  lividans transformants containing the PD 116740 
biosynthetic gene cluster accumulated an unusually large quantity 
of potential biosynthetic intermediates compared to the wild-type 
strain, as shown in Figures IV-8 and IV-9.  The possible 
intermediates of PD 116740 biosynthesis were unambiguously 
synthesized.24  By comparison of UV-Visible spectrum and 
retention time and by coinjection of the authentic samples, we 
were able to identify HT, MT, HMT, and chlorotetrangulol (CT) from 
the S.  lividans transformant.  We do not know the reason of 
presence of CT in S. WP 4669 and in the S.  lividans transformant. 
Biosynthetic investigations with this product are in progress.  So, 
from the S.  lividans transformant, all of the suggested intermediate 
compounds except DT and its methylated or hydroxylated DT were 
identified.  The data suggest that epoxidation and hydrolysis of the 
epoxide to 5,6-diol are the last steps in PD116740 biosynthesis. 
Thus, the original hypothesis that PD 116740 may be derived from 
HMT (Figure IV-1), has gained considerable support from 
molecular genetics.  The identification of enzymes governing each 
of the late stage steps should clarify the details of the correct 
sequence of steps tailoring tetrangulol. 
Recently, the detailed functions of individual enzymes of a PKS 
have been being deciphered by expressing combinations of 
different PKS genes.7-11  This suggests it may be possible to 
rationally design new polyketides by genetic engineering.  The ring 
folding pattern for angucyclines, leading to an angular ring system 1 1 3
 
(2) should be different from that leading to linear systems such as 
1. 
00,00  cos 
Further molecular genetic research on the tetrangulol and PD 
116740 biosynthetic gene clusters may give information about 
what causes the formation of an angular aromatic ring.  This would 
add a new dimension for engineering unnatural hybrid angular 
secondary metabolites. 1 1 4
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Chapter V
 
Conclusion  and  Prospects
 
Angucyclines are a subclass of the class of natural products 
known as aromatic polyketides.  Many of these compounds exhibit 
a variety of important biological activities.  The nature of the 
genetic PKS programming for aromatic polyketides is beginning to 
be deciphered.  However, the number of currently available 
aromatic PKS gene sets is limited.  The PKS gene clusters of 
angucyclines (e.g. those for the kinamycin precursor 
dehydrorabelomycin, tetrangulol, and PD 116740) as well as the 
cluster for phenanthraquinones (for murayaquinone) may be 
important additions for engineering new polyketides.  They may 
also provide further clues into the genetic programming of 
structurally more complex polyketides. 
The initial attempts in this research focused on the heterologous 
expression of PKS gene clusters from an S.  murayamaensis lambda 
library.  However, the approach was not successful, presumably 
due to the lack of key genes on the relatively small pieces cloned 
(15-20 kb).  Identification of PKS genes by heterologous expression 
after cloning large pieces of DNA (30-45 kb) in a cosmid vector was 
successful.  The entire gene clusters for production of the aromatic 
polyketides tetrangulol from S.  rimosus and PD 116740 from S. WP 
4669 have been successfully cloned in this manner and then 120 
expressed in a heterologous host.  Two PKS gene clusters from S. 
murayamaensis were also cloned by constructing a cosmid library. 
One of these was identified as apparently containing many of the 
genes for the kinamycin pathway, since it yielded a derivative of 
the known kinamycin biosynthetic intermediate kinobscurinone. 
The future efforts on PKS genetics of S.  murayamaensis, S. 
rimosus, and S. WP 4669 will focus on a number of interesting 
aspects of this biologically important class, as follows. 
a)  Sequencing of the cloned PKS genes for tetrangulol, PD 
116740, and the kinamycins will provide a clue about what causes 
a polyketide backbone, synthesized by minimal PKS gene, to yield 
an  angular instead linear polycyclic aromatic product.  This 
understanding may eventually lead us to engineer a variety of 
unnatural hybrid angular secondary metabolites. 
b) We could not identify cryptic PKS gene clusters from S. 
rimosus and S. WP 4669, probably because of the background 
activity of the host S.  lividans.  A possibly better approach to 
identify these PKS gene clusters will be to express them in  S. 
coelicolor CH999, from which two independent secondary 
metabolisms, actinorhodin and undecylprodigiosin, were deleted. 
This approach will minimize the background activities and 
uncertainties associated with the host secondary metabolism. 
c)  Tetrangulol is derived from a decaketide precursor after only 
slight modification.  So, the introduction of the tetrangulol 
biosynthetic gene cluster to other Streptomyces has a good 
potential to generate hybrid compounds by the action of the 
tailoring enzymes of host strains. 1 2 1
 
d)  Sub-cloning the tailoring enzymes such as 0­
methyltransferase, methylhydroxylase, or epoxidase from the 
cloned PD 116740 biosynthetic cluster and the tailoring enzymes 
from the kinamycin biosynthetic gene cluster will eventually lead 
to overexpression of these enzymes and each enzyme can be 
purified in an active form.  Therefore, cell-free systems prepared 
from recombinant strains that overproduce these tailoring 
enzymes are an attractive means to study the enzyme mechanisms 
of the pathways. 
e)  Introduction of the DNA of Cluster I of S. murayamaensis 
into S. lividans ZX7 and S. lividans JT46, which lack of homologous 
recombination, may produce an identifiable gene product.  This 
may lead us to identify what Cluster I codes for. 
f)  Confirming the chemical structure of PK1 and determination 
of the chemical structure of PK2 may be useful to help in 
developing a more complete description of the kinamycin 
biosynthetic  pathway. 122
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